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Marsha A. Hughes-Gay 
EXAMINATION OF THE INFORMED CONSENT PROCESS AS EXPERIENCED 
BY PATIENTS WHO UNDERWENT A DE NOVO TRANSJUGULAR 
INTRAHEPATIC PORTOSYSTEMIC SHUNT, CHEMOEMBOLIZATION OR 
RADIOEMBOLIZATION PROCEDURE  
 The purpose of this study is to examine the informed consent (IC) procedure as it 
was experienced by patients who had undergone a de novo transjugular intrahepatic 
portosystemic shunt (TIPS), chemoembolization (TACE), or radioembolization (TARE) 
procedure in an Interventional Radiology (IR) Department. The three main study aims 
and a fourth exploratory aim are as follows: (1) Describe how patients who underwent a 
de novo TIPS, TACE, or TARE procedure in an IR Department described the IC 
procedure; (2) Describe what information patients who underwent a de novo TIPS, 
TACE, or TARE procedure in an IR Department recalled being told during the IC 
procedure; (3) Describe the satisfaction of patients who underwent a de novo TIPS, 
TACE, or TARE procedure in an IR Department with the IC procedure; and (4) Explore 
how the IC experiences of patients who underwent a de novo TIPS, TACE, or TARE 
procedure in an IR Department differed according to their levels of health literacy. Using 
a qualitative descriptive design, participants were recruited from an IR department that 
performed these procedures. A total of 14 participants were interviewed about their IC 
experiences and the Newest Vital Sign (NVS) Health Literacy assessment was 
administered. The participants described the IC procedure by discussing the staff they 
encountered, their feelings during the visit, the support persons who accompanied them, 
and the decisions they made about the procedure. The participants recalled being told 
 viii 
about how their procedure would be performed, the care they would need, and the 
benefits and risks of the procedure. Most were satisfied with the information received 
during the IC procedure and found the information consistent with how they experienced 
the procedure. A few participants would have liked more visual materials, addition details 
about the procedure, simpler language, or more explanation of the medical terminology. 
No apparent differences in the IC experience could be attributed to health literacy.  These 
findings suggest that persons’ experiences during the IC process are multi-faceted and 
affected by their emotions and concerns and the nature of their encounters with their 
healthcare providers.  
 
Claire Draucker, PhD, RN, FAAN, Chair 
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CHAPTER ONE-INTRODUCTION AND NATURE OF THE STUDY 
Background and Description of the Problem 
 Patients who are scheduled for diagnostic tests and procedures often engage with 
health care professionals to complete an informed consent (IC) procedure. Healthcare 
providers (HCPs) provide information about the test or procedure, the reasons for the test 
or procedure, and its risks and benefits. After the provider has given the information and 
the patient has had the opportunity to consider the information and ask questions, an IC 
document is typically signed.  
 Skidmore-Roth and Pagana (2010) describe informed consent as follows:  
Permission obtained from a patient to perform a specific test or procedure. 
Informed consent is required before most invasive procedures are 
performed and before a patient is admitted to a research study. The 
document used must be written in a language understood by the patient 
and be dated and signed by the patient and at least one witness. Signed 
consent should be obtained by the person performing the procedure. 
Included in the document are clear, rational statements that describe the 
procedure or test. Also required is a statement that care will not be 
withheld if the patient does not consent. Informed consent is voluntary. By 
law, informed consent must be obtained more than a given number of days 
or hours before certain procedures, including therapeutic abortion and 
sterilization, and must always be obtained when the patient is fully 
competent. An individual must be of a certain legal age to give consent; 
laws vary from state to state. (p. 96) 
 
IC procedures are based on ethical principles related to autonomy and self-
determination. Physicians and nurses have an ethical duty to ensure that patients 
understand and participate in their care. The American Medical Association (AMA), in 
their Code of Ethics, states, “The patient’s right of self-decision can be effectively 
exercised only if the patient possesses enough information to enable an informed choice” 
(American Medical Association, 2012, opinion 8.08).  The American Nurses 
Association’s (ANA) Code of Ethics states that patients have the moral and legal right to 
 2 
determine their treatment, or to refuse treatment, based on the information provided to 
them.  This information should be provided in way that can be understood.  The ANA 
Code of Ethics, section 1.4, (2015) also states that the nurse has a responsibility to 
understand the moral and legal rights of patients with regard to their care: 
Patients have the moral and legal right to determine what will be done 
with and to their own person; to be given accurate, complete and 
understandable information in a manner that facilitates an informed 
decision; and to be assisted with weighing the benefits, burdens, and 
available options in their treatment, including the choice of no treatment. 
(p. 19) 
 
Further, the ANA Code of Ethics informs nurses that their primary commitment is to 
their patients, which includes having honest conversations regarding their treatment 
options (American Nurses Association, 2015, codes 2.1, 6.2). 
IC is based on the assumption that patients understand and consider information 
presented to them and feel free to make decisions about all tests and procedures. Yet 
research suggests this is not always the case, and, despite experiencing IC procedures, 
patients often do feel fully informed about procedures they undergo (Falagas, Korbila, 
Giannopoulou, Kondilis, & Peppas, 2009). Among family practice physicians, patient 
dissatisfaction with IC procedures is the seventh leading cause of litigation (Roberts, 
2003).   
One factor that might influence patients’ experiences of IC procedures, especially 
the extent to which they fully understand the information, is health literacy. Health 
literacy is defined by Ratzan and Parker (2000) as “the degree to which individuals have 
the capacity to obtain, process, and understand basic health information and services 
needed to make appropriate health decisions” (page iv). The Institute of Medicine 
estimates that 36% of adults in the US - about 90 million people - and 59% of the elderly 
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have limited health literacy (Institute of Medicine, 2004).  Limited health literacy could 
have adverse implications of IC processes, especially for complex tests and procedures. 
The Role of Nurses in Informed Consent Processes 
In the role as patient advocate, the Registered Nurse has legal, ethical and moral 
obligations to ensure the patient has the information necessary to make informed 
decisions related to their care.  Nurses often provide patients with health information in 
verbal, written, and visual formats and need to ensure that patients are able to navigate 
the multiple forms needed for IC and follow the directions on the forms provided (IOM, 
2004). Nurses should also confirm that patients fully understand the rationale, benefits 
and risks, and expected outcomes of tests and procedures because if patients 
misunderstand this information, this would lead to an uninformed choice (IOM, 2004, 
Tariman, Chochrane, Doorenbos, & Schepp, 2012).  
Study Purpose 
 Nurses and other healthcare professionals need an in-depth understanding of how 
patients experience the IC process especially for complex and invasive procedures in 
order to ensure that these processes meet their informational needs and thus allow them to 
fully participate in their healthcare. Much of the research on IC procedures is focused on 
the measurement of indices of patient understanding and knowledge of the test or 
procedure for which they are consenting, and little is known about how patients 
experience IC procedures, including their perspectives on the healthcare encounters in 
which the IC procedures are embedded.  In addition, it is unclear how health literacy 
might influence their experiences.  To examine how patients experience the IC process, 
persons who have undergone de novo transjugular intrahepatic portosystemic shunt 
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(TIPS), chemoembolization (TACE), or radioembolization (TARE) procedure will be 
interviewed about their experiences. These three procedures (defined below) were chosen 
as the focus of this study because the procedures are similar in that they are all invasive, 
associated with significant risks, and require a pre-procedure visit in which the procedure 
is described and consent is obtained.  
The purpose of this study is examine the IC procedure as it was experienced by 
patients who underwent a de novo TIPS, TACE, or TARE procedure in an Interventional 
Radiology (IR) Department. The specific aims are as follows: 
1. Describe how patients who underwent a de novo TIPS, TACE, or TARE 
procedure in an IR Department describe the IC procedure;  
2. Describe what information patients who underwent a TACE, TARE, or de novo 
TIPS procedure in an IR Department recalled being told during the IC procedure;  
3. Describe the satisfaction of patients who underwent a de novo TIPS, TACE, or 
TARE procedure in an IR Department with the IC procedure. 
In addition, the following exploratory aim was addressed:  
4. Explore how the IC experiences of patients who underwent a de novo TIPS, 
TACE, or TARE procedure in an IR Department differed according to their levels 
of health literacy.  
A Qualitative Descriptive (QD) study as described by Sandelowski (2000) was 
conducted to address the study aims. This research method was chosen as the investigator 
sought to obtain rich data based on the study participants’ own words regarding the IC 
procedure rather than data derived from pre-determined variables as would be obtained in 
a quantitative study (Neergaard, et al., 2009; Sandelowski, 2000).  This method allowed 
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patients to freely discuss what was most important to them during the IC procedure 
(Merriam, 2009; Streubert-Speziale & Carpenter, 2003).  An exploratory component of 
the study was to examine how patients of varying health literacy levels experienced the 
IC process.  
Theoretical Basis of Study 
The model guiding the study is the Common Sense Model of Self-Regulation of 
Health and Illness (CSM) (Diefenbach & Leventhal, 1996; Leventhal, Brissette, & 
Leventhal, 2003).  The CSM is a theoretical framework that explains how patients in a 
wide range of settings recognize and respond to a health threat. The CSM considers 
patients to be problem solvers who formulate and carry out action plans to address health 
threats by using a variety of cognitive, behavioral and perceptual processes (Diefenbach 
& Leventhal, 1996; Leventhal et al., 2014; Leventhal, Phillips, & Burns, 2016).  The 
model was first proposed in the early 1970’s and has continued to evolve through the 
addition of more complex structures to show how cognitive and emotional systems are 
activated and action plans are developed (Diefenbach & Leventhal, 1996; Leventhal, 
1970, Leventhal et al., 2014).  The basic CSM model appears below in Figure 1. 
According to the CSM, health threats can arise from internal or external stimuli. 
Internal stimuli include any deviation from one’s normal state including bodily changes 
resulting from an illness. External stimuli arise in the environment and could include the 
illness of another or information received from a HCP or community.  These stimuli 
initiate interacting perceptual, behavioral and cognitive responses. The structure of the 
CSM is comprised of four parts: 1) the core control unit; 2) an illness representation, 
content and structure; 3) procedures, action plans and appraisals (the output side of the 
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model); and 4) the self-system of executive function and tools (Diefenbach & Leventhal, 
1996; Leventhal et. al, 2014; Leventhal, Brissette, & Leventhal, 2003).   
Core Control Unit 
 The core control unit of the CSM is a feedback loop that permits self-regulation 
based on the representation of a health threat, action plans that could control the threat, 
and the consequences of the action plans. Early studies using the CSM model revealed 
that patients used cognitive processes to control the threat and emotional processes to 
control their emotional responses to the threat. An early study of smoking cessation, for 
example, found that patients needed both fear-inducing messages (emotional process) and 
an action plan (cognitive process) to result in action against the threat (Leventhal, Watts, 
& Pagano, 1967).  
Illness Representations, Content and Structure 
 The CSM includes five domains of illness representation that are based on 
patients’ perceptual and procedural knowledge and are described as common-sense ideas 
(Leventhal et al., 2014).  The five domains are identity, timeline, consequence, cause, and 
control.  The following figure illustrates these domains and the affective behaviors with 
which they are associated.  The feedback pathway demonstrates how the domains 
integrate with cognitive and physical behaviors which may lead to a representation of 
illness, a cue to action, and the development of an action plan.  Continuous feedback may 
then maintain or change the representation of illness.  Depending on the type of feedback 
(e.g. signs and symptoms, perceived threats), action plans may change or be abandoned 
all together. 
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Figure 1:  Early View of the Common Sense Model. From “Modeling Health and Illness 
Behavior.  The Approach of the Commonsense Model” by Leventhal, Bodnar-Deren, 
Breland, Hash-Converse, Phillips, Leventhal, & Cameron, in Baum, Revenson, & Singer 
(Eds.), Handbook of Health Psychology (2nd Edition, p. 16), 2014, New York, United 
States: Taylor and Francis Group LLC Books.  Copyright [2010] by Taylor and Francis 
Group.  Reprinted with permission. 
 
 Identity domain. Patients label their symptoms for a particular illness (health 
threat) based on the known signs and symptoms (the stimuli) of the illness as well as their 
past experiences and those of others. Once the symptoms are perceived and labeled, the 
feedback system is activated and the patients’ cognitive and emotional responses to the 
label are initiated (Leventhal et al., 2014). 
 Timeline domain.  Patients formulate a timeline for the health threat based on 
their beliefs about how an illness should progress. Patients may, for example, determine 
the illness is self-limiting and, if it does not subside, may determine an action plan is 
needed. Illnesses perceived as acute may call for immediate action plans, whereas as 
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illnesses perceived as chronic may call for action plans that are less urgent (Leventhal et 
al., 2014). 
Consequence domain.  Patients determine the anticipated consequences of the 
health threat or particular treatments based on their own experiences or those of others. 
The consequences may be financial, emotional, or physical. This domain informs the 
feedback system which may influence the patient’s choice of treatment (Leventhal et al., 
2014). 
Cause domain. Patients determine the cause of their symptoms, which could be 
an external agent, their own behaviors, and their internal susceptibilities. The cause of a 
health threat may inform the action plan with regards to the current treatment or future 
prevention of the threat (Leventhal et al., 2014). 
 Control domain.  The patient determines the treatment for the health threat based 
on whether there is a cure for or a way to control the condition. Patients determine if they 
or a HCP will control the condition (Leventhal et al., 2014). 
Procedures, Action Plans, and Appraisals 
 In the CSM, an intervention for a defined health threat is labeled a procedure. 
Procedures can be for short- and long-term outcomes and can range from taking an over-
the-counter medication to a complex medical intervention. Procedures are implemented 
by action plans and are based on illness representations (Leventhal et al., 2014). 
The Self-System of Executive Tools and Function 
 The above three systems operate in the context of executive functioning.  
Executive functioning includes monitoring system outputs, holding information in 
memories, and thoughts and behaviors (Leventhal et al., 2014).  The CSM stipulates that 
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each person has a prototype of the self and access to subjective cues of their physical self 
that activate their illness representations, which in term determine their choice of 
treatments for a particular health threat (Leventhal et al., 2014). The continuous feedback 
system provides the patient with information based on past experiences, emotional 
responses, and new information.   
CSM and the Informed Consent Process 
 The CSM provides a foundation for the current study as it identifies a number of 
theoretical structures that are highly relevant to the IC process. For example, the core 
control unit, defined in the theory as the feedback loop that permits self-regulation of 
health and illness, serves as the context in which the IC process occurs. The theory would 
suggest that prior to IR procedures, patients would have established an illness 
representation for the liver disease that necessitates the procedures and determined the 
threat of the disease. They have would have labeled their symptoms (identity domain), 
formulated a timeline (timeline domain), determined the anticipated consequences of the 
illness and the IR procedure (consequence domain), determined the etiology of their 
symptoms (cause domain), and determined if the control of the treatment lies with them 
or their HCP (control domain).  
 Information provided to patients during the IC process related to any of these 
domains can influence their decision regarding the procedure.  For example, if patients’ 
symptoms are described as life-threatening (identity domain) and acute (timeline 
domain), they may be more inclined to consent to the IR procedure (action plan) 
regardless of the risks of the procedure (consequences).  Because many participants in 
this study had severe liver impairment (identity domain) and the consequences of not 
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having the IR procedure were dire (consequence domain), these factors were likely 
salient in IC discussions.  Conversely, if participants had been asymptomatic or had 
minimal symptoms, the urgency for IR procedures indicated by the HCP might not have 
been consistent with their perception of the health threat (Leventhal et al., 2014), and 
they may have been more reluctant to consent to the procedure. 
 The consequence domain of the illness representation is particularly relevant to 
the IC procedure. The consequences, which would be the risks and benefits of having or 
declining a de novo TIPS, TACE, or TARE procedure, are central concerns in providing 
IC. IC processes, including the opportunity to ask questions, should assist patients in 
determining the likely outcomes of an action plan of having or rejecting the procedure or 
seeking alternative options. For example, participants in this study may have decided that 
the risks and discomforts associated with the IR procedure would be offset by elimination 
of the need for frequent paracentesis.  
 The if-then scenario that underlies patients’ action plans are likely to be at play 
during the IC process. Patients are tasked to decide if they have a procedure, then what 
outcomes will occur. For an IR procedure, the results could be relief of symptoms, better 
quality of life, or the slowing of the progression of the liver disease or could include be 
one of the risks associated with the procedure. Conversely, decline of an IR procedure 
could result in avoidance of the risks of the procedure but could result in decline or death 
(Leventhal Brissette, & Leventhal, 2003). The CSM, therefore, will help provide a 
theoretical elucidation of the participants’ descriptions of the IC process for the de novo 
TIPS, TACE, or TARE procedures.  The findings will be considered in the context of 
these theoretical constructs.  
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Definitions and Key Terms 
 Chemoembolization (TACE): The delivery of chemotherapy drugs directly to a 
tumor site, usually in the liver, directly by catheter through an artery.  This allows for 
higher doses of medication to be delivered to the tumor and disrupts the blood supply to 
the tumor (Morena-Luna et al., 2013). 
 Health Literacy: The reading skills, numeracy skills, and comprehension level 
needed to use health information and make decisions about one’s healthcare (Speros, 
2005). 
Informed Consent: The exchange of information between a HCP and patient 
regarding a procedure. The information includes a description of the procedure and its 
associated risks and benefits (Skidmore-Roth & Pagana, 2010). 
Informed Consent Document: A written document describing a procedure and its 
associated risks and benefits signed by patients giving healthcare providers permission to 
perform the procedure (Skidmore-Roth & Pagana, 2010). 
 Interventional Radiologist: A physician with specialized training in minimally 
invasive procedures using imaging guidance to diagnose and treat diseases (Society of 
Interventional Radiology, 2006). 
 Radioembolization (TARE): A procedure using a catheter that allows directed 
placement of yttrium-90 microspheres via the hepatic artery to emit internal radiation to 
the tumor site.  This disrupts the blood flow to the tumor and limits damage to the 
surrounding normal tissues (Salem et al., 2010). 
 Transjugular Intrahepatic Porto Systemic Shunt (TIPS): A minimally invasive 
procedure in which vascular access is obtained via the jugular vein in the patient’s neck 
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and small catheters are used to reach the liver.  Pressures within the vasculature of the 
liver are obtained and, using contrast (x-ray dye), images are obtained.  A tract is created 
in the liver using balloons and stents connecting the hepatic and portal veins resulting in 
hepatic decompression (Boyer, 2003; Boyer & Haskal, 2005; Boyer & Haskal, 2009). 
Significance and Contribution 
 The legal and ethical requirements of the IC procedure are paramount in the 
provision of patient-centered care.  If patients are to actively participate and direct their 
care, the IC procedure experience should be conducted in a way that allows patients to 
make informed decisions regarding tests and procedures.  This study will provide a rich 
description of how an IC procedure for an IR procedure is experienced within the context 
of a healthcare encounter and explore how this experience might differ for patients with 
varying health literacy levels.  The study will thus provide foundational information for 
initiatives aimed at improving IC process to improve patient satisfaction and safety. For 
example, information obtained in this study may help HCPs develop communication 
techniques that could improve the IC experience for patients or reexamine procedures 
that patients may find to be problematic.  
Assumptions and Philosophical Perspective 
The study has the following assumptions: 
1.  The HCP should provide information during the IC procedure in a 
satisfactory and meaningful way to patients.  
2. HCPs are legally and morally obligated to support patient self-determination. 
3. The IC procedure is experienced subjectively. 
4. Patients narratives will provide rich data regarding their IC procedures.  
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Summary 
 The IC procedure is an interaction between HCPs and patients with regard to an 
impending medical procedure. Information is provided to patients about the procedure, 
and they are given the opportunity to ask questions so that they can make a fully 
informed choice about undergoing the procedure. In some instances, the information 
provided to the patient can be complex as is the case of TIPS, TACE, or TARE 
procedures conducted in IR Departments. As indicated by the CSM, the HCP and patient 
both have integral roles in the decision to undergo a procedure. This chapter identified 
the need to explore the IC procedure from patients’ perspectives in their own words.  The 
purpose of this study is to examine the IC procedure as it was experienced by patients 
who underwent a de novo TIPS, TACE, or TARE procedure in an IR Department. 
Results from this study may assist in the development of strategies to improve IC 
experience for patients undergoing complex and risky procedures.  
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CHAPTER TWO-LITERATURE REVIEW  
 
Introduction 
Patients are asked to provide IC for complex medical procedures, including high 
risk IR procedures, such as a de novo TIPS, TACE, or TARE (Skidmore-Roth & Pagana, 
2010).  In the IC process, HCPs deliver medical information about procedures to patients, 
and patients then consent to the procedures by signing a formal document (Skidmore-
Roth & Pagana, 2010; AMA, 2006).  Yet research shows patients may sign IC documents 
for procedures based on information that they do not fully understand including the risks 
and benefits of the procedures (Falagas et al., 2009; Roberts, 2003). Health literacy might 
be one factor that influences the process of IC (IOM, 2004). Despite the importance of IC 
in the care of patients undergoing complex procedures, little is known about how patients 
experience the process of IC. The purpose of this study is to examine the IC procedure as 
it was experienced by patients who underwent a de novo TIPS, TACE, or TARE 
procedure in an IR Department. This chapter will address the following topics: IC process 
for medical procedures, patient experiences with IC for medical procedures, enhanced 
procedures for the IC process, health literacy and IC, measurement of health literacy, 
assessment of health literacy skills, health literacy and IC procedures, and IR procedures. 
Informed Consent Process for Medical Procedures 
 The purpose of IC for medical procedures is to provide patients with essential 
information about procedures, including benefits and risks, so patients can make 
informed decisions regarding the procedures. Patients may receive information about 
upcoming procedures from the referring physicians or from the facilities in which the 
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procedures will be performed (Davies et al., 2004; Mayberry & Mayberry, 2001). 
Information required for IC may be given to patients at different time points.  Patients 
scheduled for some procedures may receive information days or weeks in advance and 
therefore have the opportunity to discuss treatment options and seek opinions from family 
members, friends, and other HCPs (Fisher, Johnstone, & Williamson, 2011; Lin, Kan, & 
Chen, 2012; Lin, Pang, & Chen, 2012). In other cases, patients may be asked to provide 
IC immediately before undergoing urgent or emergent procedures and may have little 
time to fully consider the decision. Hospitalized patients are often asked to provide IC for 
procedures within minutes before they are delivered (Proctor, Price, Minhas, Gumber, & 
Christie, 1999; Kay & Siriwardena, 2001). In some cases, HCPs provide treatment 
without consent from patients or their legally authorized representatives if the patients 
cannot provide IC and it is deemed that a reasonable patient would agree to the procedure 
if able to do so (Easton, Graber, Monnahan, & Hughes, 2007).   
Patient Experiences of IC for Medical Procedures 
 Some researchers have investigated how patients experience the process of IC for 
medical procedures.  Studies have examined the views and experiences of patients who 
have undergone an IC process related to the amount of information received during the 
process, how the information was provided, the quality of information, when in 
relationship to the procedure the information was provided, how relationships with HCPs 
affected the IC process, communication of risks and benefits, and how the IC process 
affects patients’ sense of control and autonomy.  
Amount of Information Received 
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Research has been conducted on patients’ perceptions about the amount of 
information that is provided to them during IC procedures.  Some patients report being 
provided too much information, which they believe adversely affects their ability to make 
an informed choice about a procedure (Fisher, Johnstone, & Williamson, 2011).  In a 
study by Agnew and Jorgensen (2012), for example, 10 of 18 patients reported that they 
had received too much information prior to their scheduled surgical procedure.  
Conversely, some patients report receiving too little information. In the Agnew and 
Jorgensen (2012) study, the other eight patients claimed that they were not given enough 
information to make an informed decision.  Fisher, Johnstone, and Williamson (2011) 
reported that six of twelve patients in their study who underwent electroconvulsive 
therapy indicated they had not received enough information about the therapy, including 
details about the possible side effects. In several studies, the amount of information 
desired by patients varied significantly (Daniels & Vogel, 2012; Degerliyurt, Gunsolley, 
& Laskin, 2010; Fisher, Johnstone, & Williamson, 2011) and was affected by their prior 
knowledge of the procedure (Fisher, Johnstone, & Williamson, 2011).     
How Information is Provided 
Information regarding procedures can be provided to patients in a variety of ways. 
The information can be provided verbally by a HCP, described in pamphlets or 
documents that describe specific procedures, or embedded in the IC document. Some 
research has examined patient preferences regarding how information is delivered.  For 
example, 62% of patients in a study by Daniels and Vogel (2012) wanted access to 
information about osteopathy treatments on the internet or via email but also wanted 
verbal information about the treatments from the HCP.  The information they wanted 
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from the HCP included the possibility of having to undress (79% of participants), 
possibility of pain caused by the exam (86%), low grade risks (89%), and rare but severe 
risks (68%).  In a study of patients undergoing IR procedures, their understanding of and 
satisfaction with the procedure increased when verbal information was provided in 
addition to written information (Davies et al., 2004).  
Quality of Information Provided 
Several studies have examined the written information given to patients prior to a 
procedure and found that the quality of information and patients’ understanding of the 
material varies widely (Daniels & Vogel, 2012; Mayberry & Mayberry, 2001; Williams 
et al., 2009). Miller, Abrams, Earles, Phillips, and McCleeary (2011) compared a health 
literacy-based consent process to a standard practice in several facilities.  They reported 
that over 70% of respondents in both groups believed the physician explained their 
surgery adequately and listened to their questions.  The researchers concluded that 
physician-patient communication contributes to patients’ perceptions that they have been 
fully informed regarding their procedures.   
When Information is Provided 
Several studies have revealed that the timing of the delivery of information to 
patients undergoing procedures affects their experiences of IC.  Information can be 
provided when patients are referred for a procedure, which allows them time to review 
the information (Daniels & Vogel, 2012; Degerliyurt, Gunsolley, & Laskin, 2010).  
During hospitalizations, patients may be asked to provide their written or verbal consent 
just prior to routine care treatments by HCPs (Mahjoub & Rutledge, 2011) or just prior to 
procedures that are urgent in nature (Proctor, Price, Minhas, Gumber, & Christie, 1999; 
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Kay & Siriwardena, 2001), and this can hinder the IC process.  In a study of IC 
procedures conducted with patients requiring urgent abdominal surgery, for example, 
only 22% could recall having been told about the side effects or potential complications 
related to the surgery (Kay & Siriwardena, 2001).  A study by Proctor, Price, Minhas, 
Gumber, and Christie (1999) compared recall when IC was obtained from 48-72 hours 
prior to an endoscopic procedure to recall when IC was obtained immediately before the 
procedure in order to assess if retrograde amnesia due to the use of medications used in 
the procedure affected patient recall of the information provided to them.  These 
researchers reported there was no significant difference in patient recall at the different 
time periods and concluded that IC procedures were appropriate any time prior to 
sedation.  
Nature of Communication with HCPs  
 Several studies have focused on the role of the nature of the communication 
between patients and HCPs during the IC process. This research revealed that good 
communication between HCPs and patients is most important to patients during IC 
procedures (Agnew & Jorgensen, 2012; Daniels & Vogel, 2012; Fisher, Johnstone, & 
Williamson, 2011; Martindale, Chambers, & Thompson, 2009). The provision of tailored 
information by HCPs based on the unique needs of patients, for example, has been shown 
to enhance the IC process (Miller, Abrams, Earles, Phillips, & McCleeary, 2011).  Some 
research indicates that communication between patients and HCPs during the IC process 
is often inadequate or that patients and HCPs perceive aspects of the IC process 
differently.  Mahjoub and Rutledge (2011) found significant differences in how patients 
and HCPs perceived communication of risks associated with procedures.  For example, 
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for certain nursing procedures, the nurses reported giving more information than patients 
believed they had received. Information provided to patients may be given without the 
opportunity for patients to discuss alternatives to the procedures or in ways that are not 
tailored to their needs. In the study by Agnew and Jorgensen (2012), for example, some 
patients stated that they felt demeaned by physicians who described procedures in 
extremely simplistic language. 
Disclosure of Risks and Benefits 
The disclosure of risks and benefits is an essential element of the IC process 
(Bulen, 2003).  The risks that are disclosed to patients during the IC procedure depend on 
the likelihood of the occurrence of the risks or on the individual practices of HCPs. 
Studies that have examined the type and amount of risks revealed during IC processes 
indicate a wide variability in practices of HCPs in regards to risk disclosure (Agnew & 
Jorgensen, 2012; Mayberry & Mayberry, 2001; Rahman, Clamp & Hutchinson, 2011). A 
study by Mayberry and Mayberry (2001), for example, revealed that only 4% of patients 
wished to be informed of a risk with a 1 in 10,000 chance of occurrence from a 
gastroscopy while 27% of solicitors (i.e. attorneys) specializing in negligence cases 
wanted that same risk listed on patient information documents (i.e., IC documents).  In an 
informative review, Cardinal, Gunderman, and Tarver (2010) discussed the problems 
associated with the IC procedures for radiological exams in routine care and for patients 
with special considerations like pregnant women and children.  The authors reported that 
HCPs may not capture the full benefit-to-risk ratio of exams or procedures administered 
to patients that expose them to ionizing radiation because patients may then decline 
diagnostic or therapeutic procedures.  
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Loss of a Sense of Control and Autonomy 
Research has shown that patients can experience a loss of a sense of control, self-
efficacy, and autonomy during the IC process (Bulen, 2003; Fisher, Johnstone, & 
Williamson, 2011).  Some studies revealed that patients may perceive a lack of choice 
due to the severity of their medical condition (Waller & Repko, 2008; Agnew & 
Jorgensen, 2012) or not be aware of alternatives to procedures that might be available to 
them (Cook, Marshall, Damato & Salmon, 2010). Bulen (2003) recommends that to 
promote self-efficacy and autonomy, the IC process should be an interactive process 
between the patient and the HCP with the viewpoint and concerns of the patient at the 
center of discussion. 
Summary 
 Several research studies have documented the perceptions of patients with regard 
to the amount, type, timing and delivery of information during the IC process for medical 
procedures. The studies suggest that the amount and type of information desired by 
patients varies widely, but there is little research that identifies what patient 
characteristics or types of procedures account for this variation.  Research does indicate, 
however, that good communication with providers is associated with patient satisfaction 
with consent procedures. While some studies have focused on patients undergoing 
radiology procedures, there is lack of information on the perceptions of patients who have 
undergone a de novo TIPS, TACE, or TARE procedure.  
Enhanced Procedures for the IC Process 
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In addition to the signing of an IC document, a variety of procedures have been 
developed to enhance the IC process. These procedures include the use of technology-
enhanced IC processes, the inclusion of supplemental written materials, the inclusion of 
illustrations in written materials, and extending the time of the IC discussions.  The 
procedures have evolved in tandem with advancements in technology and an increased 
awareness of the shortcomings of relying solely on the IC document to present 
information. 
Technology-Enhanced IC Procedures 
 Studies have been conducted to determine the efficacy of using technology-
enhanced procedures to deliver information during the IC process.  As media and 
technology have evolved, these studies have transitioned from the use of video tapes to 
compact discs-read only memory (CD-ROMs) and  digital video disks (DVDs) to the use 
of iPad® technology and computer-based interactive software.  In several studies, 
patients were asked to view a brief video that provided information about their scheduled 
procedure and/or treatment and their knowledge of the material was then assessed 
(Batuyong, Jowett, Wickramasinghe, & Beischer ,2014; Cowan et al.; Luck, Pearson, 
Maddern, & Hewett, 1999; Olver, Whitford, Denson, Peterson, & Olver, 2009; Rossi, 
Guttman, MacLennan, & Lubowitz, 2005; Tait, Voepel-Lewis, Chetcuti, Brennan-
Martinez, & Levine, 2014).  In a study on IC for cancer treatments, for example, Olver et 
al. (2009) used a CD-ROM that contained text, graphics, videos and internet links 
regarding the nature and risks of the treatments.  One group of patients was given the 
CD-ROM and another was provided with standard written materials.  Comparison of 
information recall between the two groups indicated there was no significant difference in 
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the recall of the number of drugs included in the treatment, the length of the treatment, or 
the treatment goal.  Two studies examined the efficacy of procedures utilizing computer 
technology. Tait, Voepel-Lewis, Chetcut, Brennan-Martinez, and Levine (2014) used an 
iPad® interactive program, and Batuyong, Jowett, Wickramasinghe, and Beischer (2014) 
utilized interactive computer software comprised of high quality 2D and 3D graphics.  
Participants in both studies answered questions during and after viewing the presentations 
regarding their scheduled procedure, and both studies reported significantly higher recall 
of information received by the computerized interactive programs compared to 
information provided by standard written materials.  These results are congruent with 
those reported in the meta-analysis of IC intervention studies by Schenker, Fernandez, 
Sudore, and Schillinger (2011). The meta-analysis included 15 studies that evaluated the 
use audiovisual IC procedures and revealed that 11 studies demonstrated improvement in 
patient comprehension.  These authors reported that in 8 out of 10 high quality studies, 
patients who watched video media had higher information scores than patients who 
received standard IC procedures.   
 A study by Hall et al. (2012) examined the impact iMedConsent™, a computer-
based consent program adopted in the Veterans Administration (VA) health system, on 
patient comprehension.  The iMedConsent™ system allows a HCP to tailor the 
information presented to the patient while also providing the required information on the 
IC forms.  During the IC process, the HCP is able to choose a patient’s scheduled 
procedure from a pre-loaded list and provide that information to the patient. The system 
provides standardized information regarding risks, benefits and alternatives to each 
procedure along with pictures and pre- and post- procedure instructions.  The IC form can 
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be tailored to specific patients while including required information.  All signatures are 
obtained via signature pad and the information is uploaded into the patient’s electronic 
medical record.  The researchers administered a questionnaire before and after the IC 
procedure to patients who had completed a surgical iMedConsent™.  They reported that 
patient comprehension on procedure-specific risks and benefits improved from 50% to 
60% but there was no improvement in the comprehension of alternatives to the 
procedure. The researchers acknowledged that even with improvement in the post-IC 
process scores, there was a generally low level of comprehension of the material 
presented.  Hall et al. (2012) also examined patient decision-making with the use of 
iMedConsent™.  The pre-IC process questionnaire indicated that 29% of patients wanted 
their physician to be the primary decision maker, but when patients completed the post-
iMedConsent™ questionnaire, only 3% of patients wanted their physician in that role.  
The researchers concluded that the iMedConsent™ process may empower patients to 
make their own healthcare decisions.  However, the Hall et al. (2012) study also revealed 
that prior to the iMedConsent™ procedure, 85% of the patients indicated they wanted to 
know as many details as possible, but this number dropped to 25% after the IC process 
using iMedConsent™.  Additionally, while none of the participants indicated they wished 
to know as few details as possible prior to the iMedConsent™ procedure, 36% indicated 
they wished to know as few details as possible after the IC process using iMedConsent™.  
The researchers concluded that HCPs need to carefully consider the amount of 
information they provide to patients.  This conclusion is supported by the finding of 
Agnew and Jorgensen (2012) that the amount of information that patients desire is 
variable.  
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Supplemental Written Information 
 Studies have been conducted on the use of supplemental written materials during 
the IC process. Smith et al. (2012) conducted a study in which 121 trauma patients 
undergoing a surgical procedure were randomized to receive structured verbal IC 
communication or structured verbal communication with supplementary written 
materials.  Patients’ recall of risks presented during the IC process was then assessed 
post-operatively (mean of 3.2 days later). Patients provided with written materials in 
addition to the standardized verbal information recalled risks with a mean score of 64% 
whereas patients provided with standardized verbal information only recalled risks with a 
mean score of 41%.  Several studies also revealed that the use of supplemental written 
information detailing risks associated with procedures during the IC process resulted in 
better patient recall of those risks post-procedure (Armstrong et al., 1997; Inglis & 
Farnill, 1993; Makdessian et al., 2004).   
In contrast, Brown, Massoud and Bance (2003) conducted a randomized 
controlled trial in which no differences were revealed between groups that received a 
handout and those that did not.  Other studies (Courtney, 1997; Inglis & Farnill, 1993) 
found limited enhanced recall in patients who received supplemental written information. 
Inglis and Farnill (1993), for example, reported that patients receiving detailed 
information recalled only two of six risks of anesthesia. Courtney (1997) reported that 
patients who received a booklet prior to a procedure regarding anesthesia had better recall 
on only two of the six knowledge questions after the IC process than patients not 
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receiving a booklet. In addition, there were no differences in recall between the groups 
after the procedure. 
Illustrations  
 The inclusion of illustrations in written materials to convey risks associated with 
surgical procedures during the IC process seems to result in better patient recall of those 
risks. Langdon et al. (2002) studied patients scheduled for hip arthroplasty, and Chan et 
al. (2002) studied patients scheduled for thyroidectomy and parathyroidectomy.  In both 
of these randomized controlled studies, groups that received illustrated information 
recalled the information better than those that did not.  
Extended Time for Informed Consent Process 
 Studies have examined the value of extending the amount of time typically used 
for the IC process by adding formal instruction or education with a HCP in addition to 
standard consent procedures. These sessions allow time for questions and discussion.  A 
study by Dodd and Mood (1981) revealed that an intervention group receiving such 
sessions recalled more of the drugs used for chemotherapy (78%) than a control group 
(34%).  The intervention group also recalled more side effects (52% versus 36%) and 
indications for chemotherapy (86% versus 64%) than the control group.  In contrast, 
Lapid et al. (2003) reported that extended sessions did not improve recall in patients 
receiving Electro-convulsive Therapy.   
Summary 
 Some studies of enhanced IC procedures have shown improvements in IC 
outcomes with regard to patient understanding and recall of the material presented.  
However, there are also studies that have reported no difference between intervention 
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groups who received enhanced procedures and control groups who did not. Moreover, in 
some studies patients’ understanding of procedures and recall of information remained 
low overall regardless of whether enhanced procedures were used.  While multiple 
studies have been conducted about factors that influence the IC process, few have 
obtained in-depth patient narratives to better understand their perceptions of these 
procedures using their own words. 
Health Literacy and IC 
Because adequate IC processes depend on the patient fully understanding the risks 
and benefits of procedures, health literacy might be a salient factor in the IC process.  
Although health literacy is defined in a variety of ways, a common definition follows: 
“The degree to which individuals have the capacity to obtain, process and understand 
basic health information and services needed to make appropriate health decisions” 
(Ratzan & Parker, 2000). The IC process may be compromised for the approximately 90 
million Americans who have inadequate health literacy skills (US Department of 
Education, 2006). 
A concept analysis by Speros (2005) revealed that health literacy includes several 
attributes: reading skills, numeracy skills, comprehension, and the capacity to use health 
information to successfully function in the role of patient.  In addition, Speros stressed 
that being exposed to the language of health care is needed for health literacy (Speros, 
2005).   
 The catalyst for many studies on health literacy was the IOM report (2004) titled 
A Prescription to End Confusion.  Health literacy research has been conducted in various 
patient populations in community and acute settings, and researchers have concluded that 
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low health literacy contributes to poor health outcomes including less use of preventative 
health services, less knowledge of one’s medical condition, increased hospitalizations, 
and low self-reported health status (Institute of Medicine [IOM] 2004). In a systematic 
review of 96 studies on health literacy, for example, Berkman, Sheridan, Donohue, 
Halpern, and Crotty (2011) reported that low or marginal health literacy was associated 
with poor health outcomes, inappropriate use of health services, and decreased uptake of 
routine mammography and influenza vaccine.  The reviewers also reported that health 
literacy can at least partially explain some racial disparities in health outcomes. Due to 
these outcomes, low health literacy is estimated to contribute to healthcare costs of 73 
billion dollars a year in the U.S.  (Hawkins, Kantayya & Sharkey-Asner, 2010). 
Factors that affect the health literacy of individuals include ethnicity, socio-
economic status, low educational attainment, low general literacy, and older age (Institute 
of Medicine [IOM], 2004).  However, experts stress that even those patients with high 
levels of education require health information that is free of medical jargon and tailored 
to their individual needs (Benson & Forman, 2002; Institute of Medicine [IOM], 2004; 
Paasche-Orlow & Wolf, 2007). 
 In 2003, the US Department of Education conducted the National Assessment of 
Adult Literacy (NAAL) study. The findings revealed that 12% of participants had below 
basic health literacy skills (e.g., skills needed to perform simple and concrete literacy 
activities), 22% had basic skills (e.g., skills needed to perform simple and everyday 
literacy activities), 53% had intermediate skills (e.g., skills needed to perform moderately 
challenging literacy activities), and 12% had proficient skills (e.g., skills needed to 
perform complex and challenging literacy activities, ability to synthesize information). 
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Persons over age 65 scored lower on health literacy even when education was controlled. 
People with low educational attainment and socio-economic status and those who spoke a 
language other than English prior to starting school had lower health literacy scores than 
other groups (US Department of Education, 2006). 
Assessment of Health Literacy Skills 
 Given the importance of the role of health literacy in health outcomes and the 
requirements of accrediting agencies to address health literacy, tools have been developed 
to assess health literacy in clinical and community settings.  Tools commonly used to 
assess health literacy levels include the Rapid Estimate of Adult Literacy in Medicine 
(REALM), the Test of Functional Health Literacy of Adults (TOFHLA), and the Newest 
Vital Sign (NVS) (Murphy, Davis, Long, Jackson, & Decker, 1993; Pfizer, n.d.).  
Rapid Estimate of Adult Literacy in Medicine (REALM) 
 The Rapid Estimate of Adult Literacy in Medicine (REALM) is an assessment 
tool that consists of 66 words to be read out loud by the patient. The person administering 
the test marks the words that are correctly pronounced by the reader.  Scores for correct 
pronunciation are associated with a grade reading level as follows:  0-18 = ≤ 3rd grade 
reading level; 19-44 = 4th-6th grade reading level; 45-60 = 7th-8th grade reading level; and 
61-66 = ≥ 9th grade reading level.  Yet because the REALM test does not assess 
comprehension, a reader may be able to pronounce a word and not understand its 
meaning (Murphy, Davis, Long, Jackson, & Decker, 1993).  Collins et al. (2012) 
reviewed several health literacy assessment tools, including the REALM, in a systematic 
analysis.  They reported that the REALM tool has been extensively tested and is still 
widely used to assess health literacy.  Some researchers have indicated that because the 
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REALM does not assess essential components of health literacy (i.e. comprehension of 
printed information, numeracy, finding health information), it should be used to screen 
patients for their inability to read and correctly pronounce medical terms but cannot 
accurately assess health literacy (Dumenci et al., 2013). 
Test of Functional Health Literacy of Adults (TOFHLA) 
 The Test of Functional Health Literacy of Adults (TOFHLA) addresses 
comprehension and numeracy skills, both of which are considered important components 
of functional health literacy.  The TOFHLA consists of two parts. The first part is a 
written assessment in which words are missing from a sentence and the reader is asked to 
choose words to fill in these blanks.  While the words are similar, there is only one that is 
grammatically correct.  The second part of the tool consists of numeracy questions that 
assess the ability to interpret medication labels/instructions and decipher instructions on 
appointment times.  The long version is 67 items and takes on average about 22 minutes 
to administer, although a short version with 36 items has been developed.  The TOFHLA 
scores indicate three levels of functional health literacy: Inadequate, Marginal, and 
Adequate (Parker, Baker, Williams, and Nurss, 1995). The TOFHLA is widely used in 
clinical practice and is considered the standard by which other health literacy assessment 
tools are validated (Dumenci et al., 2013). 
Newest Vital Sign (NVS) 
 The NVS is a rapid assessment tool to assess health literacy. Using a nutritional 
label for ice cream, the person administering the test asks the patient six questions 
regarding information on the label.  Scores are based on the number of correct answers 
and results are placed into one of three categories. A score of 0-1 suggests high likelihood 
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of limited literacy, a score of 2-3 indicates likelihood of limited literacy, and a score 4-6 
indicates likelihood of adequate literacy. The questions require the patient to use 
numeracy and reading skills (prose literacy) as well as scan the label for relevant 
information (document literacy).  The tool can be administered in about three minutes. 
The NVS has been compared to the TOFHLA and, in the English Version, was reported 
to be more sensitive than the TOFHLA for those with marginal functional health literacy.  
The NVS is considered a valid tool for the assessment of functional health literacy.  
Pfizer has made the NVS available on its website and provides a toolkit, instructions, and 
printable documents at no charge for HCPs (Pfizer, n.d.; Weiss et al., 2005). 
Comparison of Health Literacy Screening Tools 
 No single health literacy screening tool can account for all socioeconomic and 
cultural differences in populations to provide a highly accurate score.  In their analysis of 
several health literacy screening tools, Collins et al. (2012) concluded that though several 
have been validated, additional work needs to be done to develop health literacy 
assessment tools: “At this time we are in need of a screening tool that can be used across 
different socioeconomic and cultural lines.  Current health literacy screening tools 
demonstrate different properties depending on the context of use” (p. 606). 
Health Literacy and Informed Consent Procedures 
 Because the IC process requires the patient to exchange information with the HCP 
in order to make a decision regarding their treatment and care, low health literacy would 
seemingly impact a patient’s ability to understand the information being presented and 
make informed decisions.  The Joint Commission requires that written information for 
patients to be in language they can understand and that HCPs talk with patients and 
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provide them with information that is culturally relevant and easy to understand (The 
Joint Commission, 2007, 2010).   
A few studies have been conducted on the impact of health literacy levels and the 
IC process.  Donovan-Kicken, Mackert, Guinn, Tollison, and Breckenridge (2012) 
reported that that patients find that many medical terms and phrases, even when plain 
language is used, are difficult to understand.  Using the REALM tool, researchers used a 
verbal IC process and recorded the amount of time it took for the patient to sign the 
consent form.  Those who took 6 seconds or less to sign the document scored higher on 
the REALM (Sharp et al., 2013).  In a study of 435 subjects recruited from the Improving 
Medication Adherence Through Graphically Enhanced Intervention in Coronary Heart 
Disease (IMAGE-CHD)  study (Kripalani, Bengtzen, Henderson, &  Jacobson, 2008), 
researchers reported that higher health literacy, as measured  by  the REALM, was 
associated with increased comprehension of the IC document. 
Summary 
 Health literacy may be important to the IC process as it is critical to the 
comprehension of information presented and foundational to decision-making. Several 
assessment tools are available to assess health literacy but no tool captures all of the 
nuances of health literacy. While a few studies have examined how health literacy scores 
effect IC outcomes, no studies have examined how differing levels of health literary 
might affect persons’ experiences in providing IC.   
IR Procedures  
To study patients’ perceptions of the IC process, three procedures were chosen for 
this research: de novo TIPS, TACE, and TARE. These procedures were chosen because 
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they are moderately complex procedures with risks that can be serious and life-
threatening (Boyer, 2003), thereby rendering the IC process for these procedures 
particularly important. In addition, unless performed emergently these procedures require 
a pre-procedure clinic visit in which benefits and risks are discussed with the patient.  
These visits allow patients time to process the information and discuss it with others in 
order to make a decision about whether or not to have the procedure. Moreover, due to 
the complexity of these procedures, health literacy may be an important factor in patients’ 
experiences with the IC process. To provide an understanding of the context of the study, 
the three procedures are described below. 
Transjugular Intrahepatic Portosystemic Shunt (TIPS) 
After being conducted on canines (Rӧsch, Hanafee, Snow, Barenfus, & Gray, 
1971), the TIPS procedure was first performed on humans in the early 1980s.  An 
Interventional Radiologist performs the procedure. Patients are placed in the supine 
position on the procedure table.  Support personnel in the room include nurses with 
specialized training in sedation and advanced cardiac life support and radiology 
technologists or technicians.  Once the patient is properly draped, the nurse may 
administer pain and conscious sedation medications.  In some instances, patients may 
have their procedure under a general anesthesia.  The Interventional Radiologist numbs 
the area near the jugular vein in the patient’s neck, obtains access, and uses small flexible 
catheters to reach the liver.  Contrast medium is injected and images are viewed and 
recorded using fluoroscopy and cineradiography.  The Interventional Radiologist can 
obtain hepatic venous pressure gradients and map the vascular system of the liver.  A 
tract is then created in the hepatic parenchyma using a balloon, and a stent that connects 
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the hepatic and portal veins and the hepatic system is decompressed (Boyer, 2003; Boyer 
& Haskal, 2005). 
The TIPS procedure is performed for several indications that involve portal 
hypertension including bleeding varices (e.g., esophageal and gastric), a bridge to liver 
transplant, Budd-Chari Syndrome, extrahepatic portal vein thrombosis, relief of ascites, 
and several other hepatic conditions that contribute to portal hypertension (Columbato, 
2007; Boyer &  Haskal, 2005; Boyer & Haskal, 2009).  The TIPS procedure can be used 
as a preventive measure, primary treatment, or treatment for some conditions in which 
medical management has failed (Boyer & Haskal 2005). 
Patients referred to an Interventional Radiologist for a TIPS procedure for the 
treatment of portal hypertension are assessed for risk including co-morbidities. Hepatic 
scores on the Child-Pugh or the Model for End Stage Liver Disease (MELD) indicate risk 
(Boyer & Haskal, 2005; Parvinian et al., 2013).  Conditions that are contraindicated for a 
TIPS procedures include congestive heart failure, multiple hepatic cysts, uncontrolled 
systemic infection or sepsis, severe pulmonary hypertension, and unrelieved biliary 
obstruction and as primary prevention of variceal bleeding (Boyer & Haskal, 2005).   
The creation of the tract within the liver that connects the hepatic and portal veins 
provides decompression of the portal circulation and thus relieves portal hypertension.  
As it can often be accomplished under sedation, the risks associated with a general 
anesthesia are reduced.  The minimally invasive technique of accessing the liver via the 
jugular vein in the neck reduces the risks associated with insertion site bleeding.  Because 
the Interventional Radiologist accesses a vein, there is no need for heavy pressure at the 
site of insertion as is required when an artery is used for circulatory system access, as is 
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the case during a cardiac catheterization. Risks associated with open abdominal surgical 
procedures (e.g. large incisions and deep vein thrombosis) are reduced (Boyer & Haskal, 
2005; Columbato, 2007)  
 Risks Associated with the TIPS Procedure.  Several risks are associated with a 
TIPS procedure. Boyer and Haskal (2005) state, “Creation of a TIPS ranks among the 
more complex procedures performed by interventional radiologists, and it is important 
that each physician monitor their success and complication rates” (p. 397). Stents can 
migrate into other areas within and outside of the liver (Boyer & Haskal, 2005).  In a case 
study (Rumi, 1999), a TIPS stent was found in the pulmonary artery of a patient who had 
undergone liver transplantation.  Other risks and/or complications associated with TIPS 
procedure include bleeding, infection, hepatic encephalopathy, de novo or recurrent 
ascites, shunt occlusion, stenosis, thrombosis, sepsis, hemolysis, congestive heart failure, 
and liver capsule puncture (Haskal & Boyer, 2005;  Boyer, 2003).   
Subclinical hepatic encephalopathy (HE) occurs in patients with cirrhosis and 
may predict the development of post-TIPS overt hepatic encephalopathy (Nardelli et al., 
2016).  The signs and symptoms of HE are delineated using the West Haven 
classification system.  Grade one HE includes mild confusion, shortened attention, and 
slowing of mental tasks performance.  Grade two HE includes lethargy, deficits in mental 
task ability, and intermittent disorientation.  Grade three HE includes disorientation, 
confusion, somnolence, and the inability to perform mental tasks.  Grade 4 HE patients 
are in a comatose state and unresponsive to stimuli (Casadaban et al., 2015).   
In a study by Casadaban et al. (2015) of 191 subjects who underwent a TIPS 
procedure, 91 (48%) had prior HE.  Of those subjects, 39 (43%) developed HE post-
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TIPS.  In a study of 82 cirrhotic subjects, Nardelli et al. (2016) aimed to use covert HE 
pre-TIPS as a risk factor for overt HE post-TIPS.  Of the 82 subjects, 35 (43%) developed 
overt HE post-TIPS with 77% of those subjects having been affected by covert HE prior 
to their TIPS.  The researchers indicated covert HE may be predictive of overt HE after 
TIPS.   
Older age is a significant predictor of 90-day mortality. Parvinian et al. (2013) 
reported 52% of patients over the age of 55 had died within 90 days post-TIPS procedure 
in their retrospective review at a single academic university-affiliated hospital.  Patients 
undergoing TIPS are also exposed to ionizing radiation in doses that have been 
determined to be associated with skin injuries due to the higher fluoroscopy time.  In a 
review of 135 cases, the mean fluoroscopy time was 38.7 minutes with a mean number of 
images at 231.  Injury of the skin from radiation can be observed at a dose of 2 Gy.  Of 
the 135 patient cases, 53 were exposed to a radiation dose of > 2 Gy.  Radiation adverse 
effects can range from redness to skin ulceration.  Given that TIPS patients may require 
additional procedures, the cumulative dose of radiation can increase with subsequent 
treatments (Miller et al., 2003, part 1; Miller et al., 2003, part 2). 
 Summary.  The TIPS procedure is a complex medical procedure that has 
demonstrated success in the treatment of conditions in which portal hypertension is a 
clinical component or complication.  While this minimally invasive procedure has 
benefits to the patients deemed appropriate for the procedure, it carries significant risks 
that can range from mild to severe, including early mortality.  These risks can occur at the 
time of the procedure or during the post-procedure period and patients require monitoring 
for these complications. 
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Chemoembolization (TACE) and Radioembolization (TARE) 
TACE and TARE are treatments for hepatocellular carcinoma (HCC).  In 2017, it 
is estimated there will be more than 40,000 newly diagnosed cases of HCC in the United 
States (National Cancer Institute, 2017).  In the United States, only 5% of patients with 
HCC are considered appropriate for hepatic resection surgery (El-Serag, 2017).  Liver 
transplantation is an option but is limited due to organ availability.  Patients with 
unresectable HCC with nodules in a single lobe and without portal vein thrombosis or 
liver decompensation (El-Serag, 2017) are may be considered for TACE or TARE.  
Patients are staged using a variety of tools such as Child-Pugh Score that assigns points 
based on level of encephalopathy, ascites, bilirubin, albumin, and prothrombin.  The 
Barcelona Clinic Liver Cancer Staging is a standard for evaluating prognosis and 
treatment (El-Serag, 2017).   
TACE and doxorubicin-eluting beads transarterial chemoembolization (DEB-
TACE) are treatments that obstruct the flow of blood in the hepatic artery that supplies 
blood to a liver tumor and deliver chemotherapeutic drugs. These procedures allow for 
higher intra-tumor drug delivery (Huang, Zhou, Wang, Cheng, & Ma, 2013). TACE is 
considered a first line treatment for unresectable HCC in patients whose liver function is 
preserved (Malagari et al., 2008).  DEB-TACE accounts for about half of the HCC 
chemoembolization (Johnson, 2017).   
An Interventional Radiologist, a physician with specialized training in minimally 
invasive procedures under imaging guidance, performs these procedures (Society of 
Interventional Radiology, 2006). For TACE and TARE procedures, patients are placed on 
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a table in the supine position in the IR room. Access to the hepatic circulatory system is 
obtained via the femoral artery, and the patient access site is thoroughly scrubbed and 
draped accordingly  For those patients in which conscious sedation is used, nurses 
provide pain and sedation medications.  These nurses have received training in advanced 
liver support and conscious sedation. They monitor the patient’s vital signs, pain, and 
well-being throughout the procedure.  Patients may also have these procedures under a 
general anesthesia.  In those instances, an anesthesiologist is responsible for anesthesia 
care.  A contrast medium is injected and fluoroscopy and cineradiography are used to 
visualize the vasculature of the treatment area. Using small flexible catheters and guiding 
wires, an Interventional Radiologist guides the agent to the tumor site within the liver.  
The TARE procedure is similar but microspheres containing either Yttrium-90 or 
ethiodized oil labeled with iodine or rhenium are delivered to the site (Edeline, Gilabert, 
Garin, GBourcher, & Raoul, 2015; Malagari et al., 2008). The use of TARE has increased 
in recent years (Johnson, 2017). 
 A meta-analysis by Zhang, Li, Ji, Zhao, and Lu (2015) indicated that patients 
receiving TARE had a greater survival rate than those receiving TACE (Zhang, Li, Ji, 
Zhao, & Lu, 2015).  In 2016, Facciorusso, Serviddio, and Muscatiello published a meta-
analysis comparing TACE to TARE and found that TACE was more effective in delaying 
tumor progression (Facciorusso, Serviddio, & Muscatiello (2016). Those patients treated 
with TARE had shorter hospital stays, better laboratory results, and fewer complications 
when compared to those receiving TACE (Zhang et al.). More randomized controlled 
trials are needed to compare the efficacy of the two treatments.  
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 Risks Associated with the Procedures. Risks associated with TARE include 
extra-hepatic uptake of the microspheres into other organs such as the gallbladder. 
Radioembolization-induced liver disease (REILD) has been described as a risk factor in 
these patients (Edeline et al. 2015).  A study by Kennedy et al. (2009) revealed the 
instance of REILD in a group of 515 patients was only 4%. Excessive radiation to the 
lungs can result in pulmonary fibrosis (Edeline et al., 2015). Other risks can include post 
embolization syndrome (PES), which includes symptoms such as fatigue, abdominal 
pain, nausea/vomiting, diarrhea, fever, and weight loss (Huang et al., 2013; Salem et al., 
Summary 
Studies have been conducted on factors that influence the IC experience for 
patients undergoing medical procedures or treatments, such as the mode, timing, and 
amount of information presented, but the results of these studies have been mixed. 
Researchers have also explored methods to improve standard consent procedures by 
adding print materials and illustrations, using technology-enhanced delivery platforms, 
and extending interactions between HCPs obtaining consent and patients.  Some of these 
enhancements have resulted in improvements in patient knowledge and satisfaction, but 
in many studies indices of patient knowledge about the procedures remained low.  Few 
studies have explored the experience of providing IC from the perspectives of patients 
undergoing complex medical procedures associated with significant risks. Moreover, the 
role health literacy might play in patient perceptions of their IC experiences is unknown.  
In order to improve the effectiveness and acceptability of IC procedures, more 
information is needed about how patients themselves experience IC procedures.  
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CHAPTER THREE-RESEARCH STUDY 
 
Introduction 
 This chapter describes the research design and methods used to meet the study 
aims. The following topics are addressed: research purpose and aims, research design, 
population, sampling and setting, inclusion and exclusion criteria, sample size, and 
recruitment. 
Research Purpose and Aims 
The purpose of this study is to examine the IC procedure as it was experienced by 
patients who underwent a de novo TIPS, TACE, or TARE procedure in an IR 
Department. The specific aims were as follows:  
1. Describe how patients who underwent a de novo TIPS, TACE, or TARE 
procedure in an IR Department describe the IC procedure.  
2. Describe what information patients who underwent a de novo TIPS, TACE, or 
TARE procedure in an IR Department recalled being told during the IC 
procedure.  
3. Describe the satisfaction of patients who underwent a de novo TIPS, TACE, or 
TARE procedure in an IR Department with the IC procedure. 
4. Explore how the IC experiences of patients who underwent a de novo TIPS, 
TACE, or TARE procedure in an IR Department differ according to their levels of 
health literacy.  
Research Design 
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 This study used a qualitative design as the aim was to understand the IC process 
from the participants’ perspectives. The design allowed the investigator to discover what 
was most important to patients who underwent a de novo TIPS, TACE, or TARE 
procedure by allowing them to freely discuss their consent experiences (Merriam, 2009; 
Streubert-Speziale & Carpenter, 2003).  More specifically, a QD approach (Merriam, 
2009) was used to provide a straightforward summary of the participants’ narratives 
about their consent experiences.  
 The goal of QD research is to provide a rich and pragmatic description of a 
specific phenomenon of interest. Researchers using QD stay “closer to the data” 
(Neergard, Olesen, Andersen & Sondergaard, 2009, p. 53) than do researchers using 
other qualitative methods. QD is the qualitative method least encumbered by theoretical 
frameworks as no pre-selected variables are used to constrain the collection of data 
(Neergaard, et al., 2009; Sandelowski, 2000). Sandelowski (2000) suggests this method 
may be “less sexy” (p. 334) than other qualitative methods but can provide pragmatic 
information to guide practice.  
QD differs from other methods in a variety of ways. While Grounded Theory is 
an inductive and cyclical method with the goal of development a theory, QD produces 
low-interpretive frameworks or typologies (Hood, 2012).  QD is also distinct from 
Phenomenology as the latter is used to interpret the latent meanings of the experiences of 
participants (Merriam, 2009; Neergard et al., 2009), whereas QD provides a practical 
surface description of a phenomenon.  
 The procedures used in QD studies vary but share some commonalities. Sampling 
is typically purposeful with a goal of maximum variation (Neergaard et al., 2009). Data 
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may be collected from individual participants or focus groups (Sandelowski, 2000, p. 
338). Questions used for data collection are open-ended and may be minimally to 
moderately-structured. Data collection is not limited to interviews but may also include 
artifacts and extant documents. Data include the “who, what, where, and why” 
(Sandelowski, 2000, p. 338) of the phenomenon of interest. Data collection and analysis 
may occur simultaneously. Data are presented in a variety of ways that fit the context of 
the study and are often analyzed with standard content analysis procedures (Sandelowski, 
2000) that uncover patterns in the data (Neergaard et al., 2009; Sandelowski, 2000).  
 QD was the most applicable method for this study as the investigator aimed to 
provide a straightforward and pragmatic description of how patients experience IC prior 
to undergoing a de novo TIPS, TACE, or TARE procedure rather than to develop theory 
or provide an interpretive rendering of the data. The study included purposive sampling, 
individual semi-structured interviews, and content analysis of the interview transcripts. 
Population 
The population for this study included patients who had undergone one of the 
three IR procedures within the three prior months. The three procedures were chosen for 
three reasons. First, unless urgent in nature, they require a pre-procedural visit with an 
Interventional Radiologist. For all three of the procedures, patients receive information 
about the procedures during this visit. This gives them time to consider the information 
they are given; discuss the information with family, friends, and providers; and seek out 
additional information regarding the procedure from other sources. This was consistent 
with the study aims because the investigator was interested in understanding consent 
processes that include time for consideration and deliberation. In contrast, for most other 
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IR procedures, patients present to the IR Department the day of procedure, receive 
information about the procedure, sign the consent, and then undergo the procedure 
immediately. Second, the three procedures are associated with notable risks. The 
investigator was particularly interested in how patients understand or interpret such risks 
when they are explained to them during the consent process. Patients undergoing more 
routine and less risky procedures would likely have substantively different consent 
experiences. Third, the procedures are moderately complex and thus the information 
provided to the patient during the IC procedure could be complicated. Thus the three 
procedures are similar in that they involve a pre-procedure visit, have significant risks, 
and are complex. 
Sampling and Setting 
  Purposive sampling was used in this study.  The sample included patients who 
had one of the procedures described above performed by a member of the Indiana 
Radiology Partners (IRP) practice group and had not had a revision of their procedure.  
These procedures are performed by Interventional Radiologists at Eskenazi Health 
(formerly Wishard Hospital), Indiana University (IU) Health University Hospital, and IU 
Health Methodist Hospital, all of which are located in Indianapolis, Indiana. The IRP 
provide IR services to several IU Health affiliated hospitals in central Indiana as well as 
to Eskenazi Health. The 14 Interventional Radiologists in the IRP also hold academic 
appointments with the IU School of Medicine, Department of Radiology and Imaging 
Science, ranging from Volunteer Clinical Assistant Professor to Professor in rank. The 
department provides direct clinical care to patients, participates in clinical research, and 
offers physician fellowships in IR.  
 43 
The three hospitals listed are all tertiary care centers providing advanced and 
specialized care to the Indianapolis, Indiana metropolitan area.  The hospitals also 
provide care for residents of several counties that surround Indianapolis including 
Hamilton, Hancock, Shelby, Johnson, Morgan, Hendricks, and Boone counties and 
throughout the State of Indiana.  Approximately 40-50 TIPS procedures are performed 
annually at University Hospital and 15 are conducted at Methodist Hospital. While 
TACE and TARE procedures are performed at all three hospitals, the majority of these 
procedures, approximately 20 cases per month, are done at University Hospital. 
Inclusion and Exclusion Criteria 
The inclusion criteria are as follows:  
1. Age 18 years and older. 
2. Underwent de novo TIPS, TACE, or TARE procedure in the prior three months. 
3. Participated in the IC process and signed the consent form for the procedure.  
4. Able to read, write, and speak English. 
Exclusion criteria are as follows: 
1. Family member or healthcare representative provided consent. 
2. Had a revision of the TIPS procedure.  
3. Had a repeated TACE or TARE procedure. 
4. Documented history of dementia. 
Only adults were included in the sample as the consent procedures are different 
for children and adults. While the procedures are performed in the pediatric population 
for the same indication as adults (Czauderna et al, 2006 ; Hawkins, Kukreja, Geller, 
Schatzman, & Ristagno, 2013; Huffman, 1994;  Maloglowkin, Stanley, Steele, & Ortega, 
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2000), pediatric patients provide assent for procedures and parents or guardians provide 
legal consent.  In order to reduce limited recall of the IC procedure, participants were 
interviewed within three months of their procedure.  Those patients who had TIPS 
revisions, or repeated TACE or TARE, were excluded since they would have experienced 
an additional IC procedure and may have had markedly different experiences due to their 
prior exposure to the information and the procedure.  
Sample Size 
The size for QD studies is not specified a priori, rather participants are enrolled 
until content saturation has been achieved. Sandelowski (1995) indicates that while the 
sample size in QD studies may be as low as 10, the final sample size for any study 
depends on the complexity of the research question and the homogeneity of the sample. 
Because all participants had their procedure in the same radiology department and 
experienced a similar IC process, the sample was homogeneous in that regard. However, 
due to the exploratory aim related to health literacy, the sample was to be divided into 
three groups (high likelihood (50% or more) of limited literacy, possibility of limited 
literacy, and almost always adequate literacy), and a sample size of 21 participants was 
planned. Seven participants per group were anticipated to be sufficient to investigate the 
influence of health literacy on the participants’ experiences with the IC process.  
Recruitment 
The IR Department software was used to search for patients who had a de novo 
TIPS, TACE, or TARE procedure in the prior three months. Once a list of patients who 
meet the timeframe criteria was generated by the Interventional Radiologist who was a 
sub-investigator on the study, the investigator reviewed the information to confirm that 
 45 
potential participants met basic inclusion criteria. The Interventional Radiologist holds 
the academic rank of Professor of Radiology and Surgery with the IU School of 
Medicine. The IU School of Medicine is a covered entity for the purpose of the IU Office 
of Research Administration and thus he had access to the patient information and could 
provide a list of these patients to the investigator.  
A letter introducing the study, written by the Interventional Radiologist, was 
mailed to the potential subjects (Appendix A). The investigator then contacted patients 
who met criteria by phone and offered them the opportunity to participate in the study. 
During this initial call, a brief description of the study was provided and potential 
participants’ questions were answered.  
 For those who agreed to participate, a copy of the IC document (Appendix B), 
the Indiana University Authorization for Release of Health Information for Research 
form (commonly called the HIPAA form at IU), and the audiotape consent was be sent to 
them via their preference of email, fax, or U.S. Mail so they could review the study 
consent form in depth and discuss it with family and friends if they so choose. Five days 
after the consent was sent to potential participants, the investigator called them to ask if 
they would still be interested in participating.  
Data Collection 
When the potential participants agreed to participate in the study, an interview 
was scheduled. If a potential participant did not wish to meet face-to-face, the 
investigator offered the participant the opportunity to participate via video chat or by 
phone.  All interviews, with the exception of one that was conducted in a private room in 
a public library, were conducted over the phone. 
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 Prior to the interviews, the investigator reviewed the IC document (Appendix B) 
and answered any questions the participants had regarding the study. The participants 
were asked to sign the IC document (Appendix B), the Authorization for Release of 
Information form, and the audiotape consent form.  If the interview was to be conducted 
by phone, the participant was asked to fax, email, or mail the signed consents and the IU 
Authorization for the Release of Health Information for Research form to the investigator 
prior to the interview. All participants interviewed by phone returned their documents via 
a pre-stamped and addressed envelope to the investigator. A copy of all documents was 
provided to the participants. 
 Prior to the interviews, information about the participants’ diagnoses and 
conditions, pre-procedure clinic visit dates, procedure dates, dates of signature on the IC, 
and post-procedure adverse events were obtained from the medical record in the IR 
Department and entered on the Health Summary Form (Appendix C). Demographic and 
medical information (Appendix D) was used to fully describe the study sample.  
After the required documents were signed, the investigator conducted the 
interview. The participants were asked to complete a brief demographic sheet (Appendix 
D) that included the following: date of birth, race/ethnic group, gender, and highest level 
of education. A semi-structured interview guide was developed with questions designed 
to answer the study aims, although it was used flexibly so that participants could fully 
describe those aspects of the IC experiences that were most important to them.  
The following opening statement was used: You had a procedure in the 
Interventional Radiology Department at __________ (University, Methodist, of Eskenazi 
[Wishard]) Hospital on (date).  I’d like to discuss the appointment you had before the 
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procedure when you spoke with the (physician, PA, or NP) about the procedure and what 
that experience was like.  I’ll be asking you several questions about that appointment and 
I’d like for you to think back to that meeting with the (physician, PA, NP).  Any details 
that you can provide to me about that appointment, even if they seem small or not very 
important, can be very helpful to me. You can choose to not answer a question if you are 
not comfortable doing so. 
The following questions were included in the interview guide:  
1. Tell me about the experience you had when you met with the (physician, NP, PA) 
to discuss the (chemoembolization, radioembolization, or TIPS) procedure. 
2. Who came with you to that appointment? 
3. Who spoke to you about the procedure?  (Physician, Nurse Practitioner, Physician 
Assistant, multiple people)  
4. What kind of information were you given during that appointment? 
5. Describe how you felt when (Physician, Nurse Practitioner, Physician Assistant) 
described the procedure to you. 
6. What types of questions did you (or family/friend) ask during the appointment? 
7. Tell me about any written information that was given to you.   
8. Did you search for information from other sources (i.e. internet, friends, etc.)? 
9. Now that you’ve had the procedure, describe how satisfied you were with the 
information that was provided to you. 
10. Can you think of anything that might have been more helpful to you during the 
informed consent procedure? 
The Newest Vital Sign Tool 
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Following the interview, the NVS (Pfizer Health Literacy Toolkit, n.d.) was 
administered (Appendix E). The NVS is an assessment tool for health literacy that has 
been validated against the Test of Functional Health Literacy of Adults (TOFHLA) tool. 
The TOFHLA has been widely used since it was developed in the mid-1990’s (Weiss et 
al, 2005).  The NVS uses the nutritional label for ice cream and requires the participant to 
use language and numeracy skills to answer six questions. The test can be administered in 
approximately 4 minutes. Pfizer has provided a NVS toolkit for HCPs at no cost and 
provides information on the administration and evaluation of NVS scores.  Scores of 4 to 
6 indicate adequate health literacy, scores of 2 to 3 indicate the possibility of limited 
health literacy, and scores of 0 to 1 indicate limited health literacy. The format of the test 
is familiar to participants because a standardized nutritional label is seen on all pre-
packaged foods for sale in the United States. (Parker, Baker, Williams, and Nurss, 1995; 
Pfizer Health Literacy Toolkit, n.d). The NVS English version has an internal consistency 
of Cronbach α=0.76 with good criterion validity (r=0.59, P<0.001).  There is no ceiling 
effect in the NVS as seen in the TOFHLA, and the NVS may be more sensitive for those 
with marginal health literacy levels than the TOFHLA (Weiss et al., 2005).  
The NVS was chosen for this study as our aim related to health literacy is 
exploratory and the NVS is less burdensome and perhaps less threatening than other 
tools. Because it can be administered in approximately three minutes while the TOFHLA 
can take between 18 and 22 minutes, the NVS was less likely to lead to participant 
fatigue following the semi-structured interview, which was the primary data collection 
strategy.  
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Compensation 
Participants were paid $20.00 in the form of a gift card after completion of the 
interview and NVS assessment. The amount of compensation was minimal and was not 
viewed by the investigator as being coercive.   
Data Management  
The interviews were transcribed by the investigator.  All identifying information 
was removed from the transcripts, and each transcript was identified by an identification 
number (001, 002, etc.).  The transcripts were kept in electronic form in a Box Health 
Data Account (BHDA) on a computer that had password protection. Hard copies of 
transcripts were kept in a locked file cabinet.  
Data Analysis 
The data were analyzed with standard content analytic procedures using the 
following the following steps (Miles, Huberman, & Saldaña, 2014):  
 Step One: Review of Transcripts. The investigator read all of the transcripts 
several times to fully understand the experiences of the participants. The investigator’s 
general impressions of the interviews were described in memos. A brief case description 
was written for each participant.  
 Step Two: Extraction of Text Units. The investigator highlighted all text units 
(e.g., sentences, phrases, words) related to the IC procedure.  
 Step Three: Coding. The investigator then coded all text units. Saldaña (2009) 
defines a code as “a word or short phrase that symbolically assigns a summative, salient, 
 50 
essence-capturing, and/or evocative attribute for a portion of language-based or visual 
data” (p. 2).  The investigator’s dissertation chair verified the codes.   
 Step Four: Display of Data. Codes were placed into a case-by-variable table as 
described by Miles, Huberman, and Saldaña (p. 224). This table was structured with 
cases presented on the vertical axis and variables of interest on the horizontal axis. The 
rows were divided into three sections: adequate, possibly limited, and limited health 
literacy levels as assessed by the NVS tool. The table was also divided into three main 
columns in order to organize the codes to answer each aim. The three main columns were 
labeled as follows: (1) IC Experience, (2) Information Provided, and (3) Satisfaction.  
Column 2 was further divided into Verbal Information and Written Information, and 
Column 3 was further divided into Helpful and Non-helpful aspects of the IC experience.  
Each code was placed in the appropriate cell by the investigator.   
 In order to ascertain if there were overt differences among the three IC 
experiences for each of the three procedures, data related to each of the three procedures 
were highlighted with different colors on the table and compared. No differences were 
noted, seemingly because the three procedures were of similar risk and complexity.   
 Step Five: Categorization. The codes in each column were categorized and 
summarized for each study aim. The codes in Column 1 were categorized to identify the 
most salient aspects of the IC experience from the participants’ perspective, the codes in 
Column 2 were categorized to identify the information the participants recalled being told 
about their procedures, and the codes in Column 3 were categorized to identify aspects of 
the IC procedure the participants found to be helpful or not helpful. The investigator’s 
dissertation chair assisted the investigator develop the categories. The final categories 
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were developed through discussion and consensus and verified by a review of the 
transcripts.   
 Step Six: Narrative Summary. Once the codes in each column had been 
categorized, the investigator wrote a narrative description of the categories as well as a 
summary of each column.  
 Step 7: Analysis for Aim 4.  To explore how the IC experiences of the 
participants differed according to their levels of health literacy, the sample was divided 
into groups based on their scores on the NVS (Pfizer, n.d.). The narratives of the groups 
were examined for explicit references to issues that might reflect the influence of health 
literacy on their experiences during the IC process. Remarks were highlighted that 
suggested that the participants (a) did not understand, or had trouble understanding, any 
information presented to them, either verbally or in the consent form; (b) were given 
information with terms that were too technical or difficult to understand, or (c) had 
misinterpreted information given to them.  Data display tables were developed in which 
such remarks were divided according to the health literacy groups. The table was then 
used to explore if the health literacy groups showed any manifest differences in the 
number or nature of such remarks. 
 An exploratory ad hoc examination of group differences was also conducted. 
Several factors discussed in the participants’ narratives that might possibly be related to 
health literacy and that could be easily quantified or dichotomized were identified. These 
factors included (a) the number of risks and benefits identified by the participants, (b) 
whether or not the participants sought information from the internet, (c) whether or not 
they asked questions during the IC process, and (d) whether or not they were satisfied 
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with the IC process generally. To examine if the number or risks and benefits recalled 
differed among the two groups, a Fisher’s exact test was conducted (Pagano & Gauvreau, 
2018).  To determine if the groups differed according to whether or not they searched the 
internet, asked questions during the IC process, or were satisfied with the IC process, a 
Fisher’s Exact Test was conducted (Pagano & Gauvreau, 2018). Significance was set at 
0.05.      
Evaluative Framework 
 The evaluative framework for qualitative research as described by described by 
Miles, Huberman, and Saldaña (2014) was used to ensure the quality of the findings. The 
criteria from this framework used in this study are as follows: objectivity/confirmability, 
dependability/auditability, authenticity, and transferability.  
 Objectivity/confirmability.  Objectivity and confirmability is the 
acknowledgement of the need to remain neutral from investigator bias (Miles, Huberman, 
& Saldaña, 2014).  In order to assure objectivity and confirmability, the investigator was 
attune to personal biases that might affect her findings. This was particularly important as 
the investigator has previously worked in the IR Department at Eskenazi Hospital 
(formerly Wishard Hospital), was the research coordinator at the Imaging Science 
Division at the IU School of Medicine, and had a working relationship with many of the 
staff and personnel in the IR Departments where the study will be conducted. She thus 
recorded any thoughts or feelings regarding data that seem to be related to her past 
experiences and personal beliefs and reviewed these memos with her dissertation chair.  
 Dependability/Auditability.  Dependability and auditability refers to the 
consistency and stability with which study procedures are enacted (Miles, Huberman, & 
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Saldaña, 2014).  The investigator ensured that the procedures of the study as detailed in 
this proposal were consistent with the QD method and were followed regularly 
throughout the study process. Any deviations from the procedures as presented were 
discussed with the investigator’s dissertation chair and in some instances with her 
dissertation committee. The investigator arranged regularly scheduled meetings with her 
dissertation committee chair to obtain feedback regarding consistency of study 
procedures (Miles, Huberman, & Saldaña, 2014).  In addition, all original memos, 
transcripts, coding documents, and data displays were maintained as an audit trial and 
periodically reviewed by the dissertation chair.   
 Credibility/Authenticity.  Credibility and authenticity is the “truth value” of the 
findings (Miles, Huberman, & Saldaña, 2014). In order to assure credibility and 
authenticity, the investigator designed a semi-structured interview guide to elicit rich and 
meaningful data related to the study aims. The transcripts were regularly reviewed by the 
investigator’s dissertation committee chair to provide feedback on the investigator’s 
interviewing techniques. The investigator was able to show how the findings were clearly 
and systematically drawn from the data by the use of the case-by-variable table described 
above (Miles, Huberman, & Saldaña, 2014).   
 Transferability.  Transferability is the ability to apply study findings to other 
contexts or populations (Miles, Huberman, & Saldaña, 2014). The investigator described 
the population and context of the study fully so that users of the findings will be able to 
determine the applicability of the findings to their own settings. A full description of the 
IR settings in which the participants had their IC procedure conducted and a detailed 
description of the study participants is provided in all reports. For example, demographic 
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information regarding gender, socio-economic status, ethnicity, and age of the sample is 
described fully so that readers can determine if these study findings can be applied to 
other persons receiving IR procedures.  
Application 
The study findings will inform HCPs on how patients experience the IC process 
for complex IR procedures.  The results provide information about how IC procedures 
might be improved to ensure patients have been fully informed and satisfied with the 
procedures. The study will inform agencies and facilities who strive to meet The Joint 
Commission standards with regard patient communication as detailed in their standard 
(2010) entitled: Advancing Effective Communication, Cultural Competence, and Patient 
and Family Centered Care 
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CHAPTER FOUR-RESULTS 
Introduction 
 This chapter presents the study findings.  First, the outcomes of recruitment 
efforts and a description of the sample characteristics are provided, followed by a brief 
description of the interviews.  The major portion of the chapter is structured according to 
the study aims and reveals how the participants described the IC procedure, what 
information they recalled from the IC procedure, and their satisfaction with the IC 
procedure. The results of the exploratory aim related to health literacy are also addressed.  
Sample 
 All participants were recruited from one hospital site from June 2016 through 
February 2018.  Although the study protocol initially included only persons undergoing 
de novo TIPS procedures, persons undergoing TARE and TACE procedures were added 
to bolster enrollment following a protocol review by the Simon Cancer Center Scientific 
Review Committee. These procedures are of comparable risk and complexity to the TIPS 
procedure.  
 Eighty-three persons had one of the three IR procedures during the recruitment 
period, met study criteria, and were sent a letter inviting them to participate in the study. 
When contacted by the investigator, 46 (55.4%) agreed to review the IC document and 
consider participation, and 17 (36.9%) of those persons agreed to participate. Many of the 
persons contacted declined to participate for a variety of reasons: they were in extended 
care facilities, very ill, incarcerated, or deceased. In some cases, potential participants’ 
phones had been disconnected or they could not be reached with available contact 
information. Two of these persons who agreed to participate did not respond to multiple 
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follow-up attempts to schedule interviews and were considered screen failures.  
Interviews were therefore conducted with 15 persons. One of these persons had had a 
TIPS revision between the time he agreed to review the study consent document and 
when he returned it to the researcher. The investigator was unaware of the revision at the 
time of the interview but withdrew the person’s data once this became known as he no 
longer met study criteria. The final sample included 14 participants, which represented 
16.8% of those eligible.  
The demographic characteristics of the sample can be seen in Table 1 (Appendix 
F).  Of the 14 participants, eight (57.1%) were male and six (42.8%) were female. They 
ranged in age from 38 to 73 years of age with a mean age of 58 years. Eleven (78.5%) 
identified as White, 2 (14.3%) as White and Native American, 1 (7.1%) as Black, and 1 
(7%) as Hispanic. Seven had a high school diploma, 3 had some college, 2 had less than a 
high school diploma, 1 had a bachelor’s degree, and 1 did not disclose educational level. 
Twelve subjects underwent a de novo TIPS procedure due to portal hypertension 
caused by cirrhosis of the liver.  Two subjects underwent a TARE procedure due to 
hepatocellular carcinoma (HCC).  All but one participant had a regularly scheduled visit 
prior to the procedure in which they provided consent.  One participant had an emergent 
procedure in the hospital and thus provided consent immediately prior to the procedure.  
Description of Interviews 
 Thirteen interviews were conducted over the phone, and one was conducted in 
person in a private room of a public library close to the participant’s home. The semi-
structured interviews ranged in length from approximately seven minutes to just over 
thirty minutes.  
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 All the participants were alert and oriented and answered all of the interview 
questions and completed the health literacy assessment. All could recall the pre-
procedure clinic visit to the Interventional Radiologist during which their procedure was 
discussed and they provided consent. Many were able to recall specific details about the 
visit, including interactions with several HCPs and ancillary staff, who accompanied the 
participants to the visit, and testing that was also completed at the visit. In response to 
questions about the IC process, participants often discussed their ill health more 
generally, the procedures they had experienced, and their overall health outcomes. 
Because this information provided a context for the questions about the IC process, 
participants were welcomed to discuss these experiences. However, when they were 
redirected to discuss their IC experiences more specifically, all were able to focus on this 
topic. No participants became upset or distressed when answering interview questions. 
All completed the entire interview, although some participants were more verbose than 
others. Two interviews were interrupted; one due to dropped cell coverage and the other 
due to an urgent situation for the interviewer.  These interviews resumed within less than 
15 minutes after the delays. 
Findings 
 The findings are first discussed according to each of the three main study aims. 
For each main aim, the key topics discussed by the participants are identified and 
described.  Examples and verbatim quotes from the participant transcripts are provided to 
support the findings presented.  Following the discussion of each aim, an extended quote 
from one participant that exemplifies several aspects of the findings about that aim are 
presented. Next, two case studies are provided based on the experiences of two 
 58 
participants who provided rich detail about their somewhat contrasting IC experiences.  
Finally, the findings related to the exploratory aim related to health literacy are discussed. 
Aim One: Describe how patients who underwent a de novo TIPS, TACE, or 
TARE procedure in an IR Department describe the IC procedure 
 The initial interview question was open-ended and asked subjects to describe the 
IC procedure. This question was purposely broad so that the investigator could determine 
which characteristics of the IC procedure the participants were most likely to remark on 
before the interview moved on to more structured questions. This strategy is based on the 
assumption that participants’ remarks to such opening questions reveal particularly 
salient or memorable aspects of an experience. In response to the initial interview 
question, most participants discussed the quality of their interactions with providers 
during the IC visit, the emotions they experienced during the visit, support persons 
present at the visit, and the decision to have the procedure.  
Quality of interactions with providers.  Many of the participants, when asked 
about the IC process generally, commented about the quality of their interactions with the 
staff obtaining IC and the IR physician who would perform the procedure. Some 
participants first described the interactions they had with support staff in the clinic prior 
to meeting the physician.  The participants recalled that these staff members obtained 
their vital signs and obtained basic health information.  The participants also recounted 
how a nurse practitioner or physician’s assistant obtained their medical history and 
explained their planned procedure. The participants generally remarked that these 
interactions were amiable. A 58-year-old man who underwent a TARE procedure stated, 
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“And he [physician’s assistant] was very informative.  He was pretty good.  It was just 
pleasant, that I remember.”  
During the IC visit, the participants also interacted with the IR physician who 
would perform the procedure, and many discussed this interaction in some detail. Several 
remarked about the IR physician’s extensive expertise in performing the procedure, his 
national reputation, his high success rate, and how highly he came recommended by the 
participants’ primary care physicians or liver specialists. Some discussed his demeanor 
during the interaction, remarking that he seemed “very sure of himself,” although several 
indicated that they wanted an IR physician who was highly self-confident.  A 61-year-old 
woman who underwent a de novo TIPS procedure stated, “I felt relieved that everything 
he’d done, he’d done for years.  And it wasn’t like his first rodeo, you know.” 
Emotions experienced during the visit. In describing the IC visit, many 
participants focused on the feelings that the visit provoked. Several indicated that they 
felt frightened when the IR provider described the de novo TIPS, TACE, or TARE 
procedure. A 73-year-old woman who underwent a de novo TIPS procedure stated, “I 
was scared as I could be.  I’m pretty tough, but I was.” Some worried about undergoing 
the procedure generally, while others had concerns about specific risks such as infection 
and bleeding. A 47-year-old man who underwent a de novo TIPS procedure became 
concerned when the provider stated, “ ‘Obviously, we’re slitting your jugular vein, the 
last thing we want you to do is have high blood pressure and bleed out on us.’ ” A few 
participants did not feel afraid at the time of the IC visit but became fearful when they 
went home and considered the information they were given about their procedures. A 59-
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year-old woman who underwent a de novo TIPS procedure stated, “I wasn’t scared at 
first. It was when I got home and started thinking about it.”  
Some participants indicated they had no fear or concerns when the IR procedure 
was described to them. Because many had been ill for some time and had endured years 
of medical testing, they had become accustomed to invasive procedures.  Even the 
possibility of death did not concern a few of them.  A 47-year-old man who underwent a 
de novo TIPS procedure stated, “I have no fear really when it comes to things like that.  If 
I’m going to die, I’m going to die.”  Others were not fearful or worried because they had 
faith the procedure would go well. A 61-year-old woman stated, “And I just said to him 
[IR physician], I’m not gonna die on the table.  Cause God’s not ready for me to die yet.  
You know, he’s not done with me yet.”   
Support persons present during the visit.  When describing the IC visit, many 
participants indicated they brought someone with them who could provide support. The 
participants indicated that it was important to have someone accompany them to this 
appointment to help them remember information provided, ask questions, give emotional 
support, and provide practical assistance, such as driving them to and from the clinic. The 
support persons included friends, significant others, spouses, and other family members.  
During the IC procedure, however, only a few of the support persons asked questions 
regarding the IR procedure to be performed. A 58-year-old man who underwent a de 
novo TIPS procedure stated, “I took my wife.  We’re currently separated, but we still get 
along really well.  I took her along with me just so I’d have somebody with me.” 
The participant who had an emergency de novo TIPS procedure in the hospital 
did not have a support person present when he provided IC. This participant, a 49-year-
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old man, stated, “There was nobody at the hospital . . . so I had nobody to turn to.  I had 
to get on the phone to call my wife and daughter.”  
 Decision to have procedure.  When asked to describe the IC procedure, many 
participants focused on their decision about whether to have the IR procedure that had 
been recommended to them. After hearing the risks and benefits, they determined that the 
procedure was the best choice for their current health status and could potentially 
improve their quality of or extend their lives.  A 59-year-old woman who underwent a de 
novo TIPS stated, “But the more and more I was having to go and get drained, I just felt 
it [TIPS] was a better option for me cause it was wearing me down.” A 49-year-old man 
who underwent a de novo TIPS procedure stated, “At this point I was, my personal 
opinion, if it was available to us finally, it was the only smart option we had left.”  A few 
participants had decided before the IC process that they would have the IR procedure 
done.  A 60-year-old man who underwent a de novo TIPS procedure stated, “I needed 
this procedure done. Before I even got a chance to talk to Dr. X, I wanted to do it.”  A 73-
year-old woman who underwent a de novo TIPS procedure discussed the choice of 
having the procedure with her family and stated, “It was a decision that the girls [her 
daughters] and I made before I got there [to the IC visit].” 
  Summary. Most of the participants, when describing the IC procedure, talked 
about the staff they encountered, the feelings they experienced during the visit, the people 
who came to the IC visit with them, and the decisions they made about having the 
procedure. A 58-year-old man who underwent a de novo TIPS procedure covered several 
of these topics succinctly:  
I mean, I thought it [the IC procedure] was okay.  I mean, it’s all kinda 
scary to me no matter what.  Just because of, what they’re doing . . . I 
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mean they’re going in main arteries and what have you.  It’s just kinda 
scary stuff.  You just don’t know, you know.  Okay, what could happen?  
And the bad part about it is, you don’t know what questions to ask either, 
because you don’t know enough about it.  At least I didn’t know enough 
about it.  But I mean, as far as the meeting, it was pleasant.  They were 
very informative.  They told me everything that, at least I could think of, 
as far as questions go. 
 
Aim Two: Describe what information patients who underwent a de novo 
TIPS, TACE, or TARE procedure in an IR Department recalled being told during 
the IC procedure. 
 When the participants were asked what information they recalled being told 
during the IC procedure, they focused on being told about how the procedures were 
performed, the care that would be required, and the risks and benefits of the procedures.  
Some of the information was provided to them as a routine part of the IC visit and some 
information was provided to them in response to questions they asked.  Most of the 
information was provided verbally by the IR physician or staff member, but some 
participants were given written information such as hand-written drawings or pamphlets 
or booklets describing the procedure.  Although the sections below focus on information 
given to the participants during the IC visit, they had often received some information 
about the procedures from their HCPs before the visit. A few had also received 
information from family or friends familiar with the procedure or from internet sites. 
 How the procedures were to be performed.  Most participants recalled being 
given information about technical aspects of the procedure. A 61-year-old woman who 
underwent a de novo TIPS procedure stated, “Dr. X came in and talked to me again and 
totally explained how the procedure would work.  How they would do the procedure 
itself.”  Several were told how the liver would be accessed via “arteries” in the groin or 
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neck. Some who underwent a de novo TIPS procedure were informed that a stent would 
be placed in their liver and the liver would be accessed through the jugular vein. Those 
who underwent a TARE procedure were told about the Y-90 device. 
 Care needed for the procedures.  Some participants recalled being told about 
the care they would receive before, during, and following the procedure. A 38-year-old 
woman who had a de novo TIPS procedure stated she was told “everything involved as 
far as nursing, people that would be in the operating room, as far as like anesthesiologists 
and students and things like that ....”  Some participants asked and were given details 
about how long they would be in the hospital or would be “down” after their procedures. 
A 58-year-old man who underwent a de novo TIPS procedure stated, “As a matter of fact, 
I don’t think I had any other questions other than how long am I going to be down.”  
Some also asked about and were provided instructions of post-procedure restrictions on 
their activities, such as the length of time after the procedure that they should not lift 
heavy objects. A few recounted being given information about what to do if 
complications arose after discharge.  For example, a 65-year-old woman who had a de 
novo TIPS procedure was told to go to the emergency room if she experienced pain. 
 Benefits of the procedures.  Many of the participants recalled being told the 
benefits of the procedure. These benefits included decreasing the need for frequent 
paracentesis, increasing the chance of getting on the liver transplant list, stopping 
intestinal bleeding, and extending life. A 47-year-old man who underwent a de novo 
TIPS procedure stated, “It was gonna allow me to get the blood flowing from my liver 
and below back into the heart and moving better.”   
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Risks of the procedures. All participants recounted being informed about risks 
associated with the procedure.  The participants most often recounted being told the risk 
of bleeding. Some had been told they could develop blood clots during or after their 
procedure or could possibly “bleed out.”  A 65-year-old woman who had a de novo TIPS 
procedure stated, “There was always a possibility of extra bleeding cause you go into the 
liver.” A few participants recalled being told about risks related to post-procedure 
encephalopathy including confusion and the potential for hallucinations.  A 38-year-old 
woman who underwent a de novo TIPS procedure stated, “Having the blood flow back 
might make me a little confused for a while.  And if it continued, I might need to go on 
medication.  If not, that was great.” Although less frequently mentioned, some 
participants recalled being told of the risks of incision opening and infection.   
Almost half of the participants said they were told during the IC process that there 
was risk of dying during the procedure. Some were given specific mortality rates. A 66-
year-old-man who had a de novo TIPS procedure stated, “Yes, I had a chance of dying.  
But it was like two or five percent.”   
 After being told about the risks, some participants concluded they were minor 
whereas others concluded they were serious. A 60-year-old man who had a de novo TIPS 
procedure was unable to recall any specific risks but had determined that he did not need 
to be worried about them. He stated, “I mean, it wasn’t nothing major.” On the other 
hand, a 57-year-old man who had a de novo TIPS procedure stated, “He [the physician] 
did say there was a fair amount of risk to the procedure itself.” A few recalled being told 
they were at a lower risk for potential complications because their health status was good.   
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 Summary:  Most of the participants recalled being told about how their procedure 
would be performed, the care they would need, and the benefits and risks of the 
procedure. A 61-year-old woman who underwent a de novo TIPS procedure described 
receiving information during the IC process: 
Dr. X came in and talked to me again.  And totally explained exactly how 
the procedure would work.  How they would do the procedure itself.  
What it [the stent] had to go through and go down and to be able to put the 
shunt in my liver.  And he did specify that there is a chance of death with 
any surgery. . . I asked him to explain to me and to draw, actually draw a 
diagram kind of thing exactly how the procedure’s gonna go.  And they 
showed me. 
 
Aim Three: Describe the satisfaction of patients who underwent a de novo 
TIPS, TACE, or TARE procedure in an Interventional Radiology Department with 
the IC procedure. 
 When asked if they were satisfied with the IC procedure, all but a few said they 
were satisfied.  Many of the participants responded to this question, however, with 
comments about their satisfaction or dissatisfaction with the IR procedure, the outcomes 
of the procedures or with their current health status. When asked to consider the IC 
procedure specifically, they were able to do so and identified several sources of 
satisfaction or dissatisfaction.  
 Satisfaction with IC process.  In regards to the IC process, most participants 
were satisfied. They were pleased with the quality of information they received, the 
amount of time staff spent giving information on their procedures during the clinic visit, 
and congruency between the information provided and their actual experience with the 
procedure.   
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Most participants felt they were given ample and accurate information about the 
procedure they were to undergo. The information provided a feeling of “safety” and these 
participants felt they knew “exactly” what was going to happen to them during their 
procedure. A 59-year-old woman who had a de novo TIPS procedure stated, “Well, he 
[the physician] explained it [the procedure] thoroughly so I understood it.  He did a very 
good job explaining it to me.”  
 Some participants appreciated the amount of time taken during the pre-procedure 
visit to explain the procedure.  Several said they were able to ask questions and received 
the information they needed about their procedure.  A 73-year-old woman who had a de 
novo TIPS procedure stated, “After he [physician] got done with his thing, he had to tell 
me both sides.  He gave me a long enough time.  He just didn’t hurry me up and hurry me 
out.” 
 Some participants were pleased that the information they received during the IC 
process was congruent with what actually happened during the IR procedures. They felt 
prepared for the procedure and did not experience any surprises.  A 62-year-old woman 
who had a de novo TIPS procedure stated, “I was very satisfied.  They told me exactly 
what was going to be done and what the outcomes should be.  It’s [liver stent] working, 
it’s doing what it’s supposed to be doing.”  
Dissatisfaction with the IC process.  A few participants, however, expressed 
dissatisfaction with the IC process.  These participants were unhappy because they had to 
wait a long time for their IC appointment, were not shown anatomical models/diagrams 
to help them understand the procedure, and did not have all their questions answered to 
their satisfaction.   
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One participant was perturbed about the wait time for his pre-procedure visit. A 
47-year-old man who had a de novo TIPS procedure stated, “He [IR physician] didn’t 
even make it into the room until 5:15 or 5:20.  Kinda ticked me off considering I sat there 
for an hour and twenty, fifteen minutes or whatever.”  This participant was also 
dissatisfied with the visit for a number of other reasons. For example, he complained that 
the diagrams of his procedure were hand-drawn rather than professionally printed. He 
stated, “I mean I would think with what he [the IR physician] considered basically a 
hundred-thousand-dollar surgery, it wouldn’t be him hand drawing a liver on a scratch 
piece of paper.” 
Another participant, a 66-year-old man, expressed dissatisfaction with the 
answers received from the HCPs in response to his questions during the IC process about 
how the procedure would be done.  This participant sought additional information about 
the procedure on the internet and from a friend who was a physician. Another participant, 
a 58-year-old man who had a TARE procedure, would have appreciated the opportunity 
to discuss additional treatment options during the IC process. He stated he wished the IR 
physician “would give me other options besides Y90.  That’d be helpful.  I mean, you 
don’t do it every day.” A couple of participants mentioned that they did not understand 
some terms used during the IC process. A 66-year-old man who underwent a de novo 
TIPS procedure stated, “…[They should use] plain language, I don’t understand the 
medical terms and all that.” 
A few of the other participants complained about other aspects of their 
experiences with the procedure but not related to the IC process. These complaints 
included poor communication with the waiting family and friends post-procedure, being 
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cared for by unfamiliar providers following the procedure, and a variety of issues related 
to post-procedure care such as being moved to multiple rooms and conflicts with 
roommates.  
 Summary:  Most participants were satisfied with the IC process because they 
obtained the information they needed and the information they received matched their 
actual experiences with the procedure.  A typical response to the IC process was offered 
by a 60-year-old man who had a de novo TIPS procedure:  “I mean they pretty much 
explained it to me.  It was explained to me just right.  They couldn’t have done a better 
job.”  The few participants who were dissatisfied would have liked professional 
diagrams, more information, and explanations in simple language. 
Participant Exemplars 
 In order to provide a more in-depth description of the overall IC process from the 
participant perspective, two participants’ experiences are described in some detail. The 
participants used for these exemplars are referred to as Participant A and Participant B. 
These participants were chosen as exemplar cases because they provided particularly 
robust descriptions of their overall IC experience and because they had experiences that 
differed considerably from each other. 
 Participant A. Participant A was a 65-year-old woman who underwent a de novo 
TIPS procedure for a diagnosis of cirrhosis of the liver.  She had been informed by her 
liver specialist that she would go into liver failure within a couple of years. Her goals for 
the procedure were to get onto the liver transplant list and to improve her health enough 
to have gastric sleeve surgery for weight loss.  The liver specialist had spoken to her on 
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several occasions about the TIPS procedure, and she felt as if she understood the need for 
the procedure.   
 When she met the IR physician to discuss the de novo TIPS procedure during the 
IC visit, he mainly reinforced the information given to her by the liver specialist.  
Participant A said the information she received from the liver specialist and the 
information she received from the IR physician and the staff were consistent.  During the 
IC visit, she asked questions related to her length of stay in the hospital, how her pain 
would be controlled, and if there would be any activity restrictions after the procedure. 
Participant A was told the major risks associated with a TIPS procedure, especially the 
risk of bleeding and the possibility that she might develop blood clots.  Participant A’s 
sister came with Participant A to the IC appointment, and while her sister did not ask any 
questions, she did take some notes during the discussions.  
 Overall Participant A was satisfied with the IC process for the de novo TIPS 
procedure. She did not feel rushed during the IC procedure appointment, and the IR 
physician and his assistant took ample time to answer all of her questions to her 
satisfaction. However Participant A would have liked some of the medical terms, like 
“jugular,” explained to her and felt she would have benefitted from seeing pictures of 
how the procedure is performed.   
 Participant A did seek additional information about the procedure from other 
sources. She spoke about the procedure with an acquaintance whose relative underwent a 
de novo TIPS procedure. Moreover she looked for information on the internet, but said 
she believed that it “drives some doctors crazy” when patients obtain information in this 
way. 
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 Participant A’s decision to have the de novo TIPS procedure was straightforward; 
while she was concerned with the risks, the possibility that she could get on the liver 
transplant list outweighed any concerns she had about the safety of the procedure. 
Although her desire for a liver transplant was the main factor driving her choice to have 
the de novo TIPS procedure, her decision was also influenced by the trust she had in her 
liver specialist, who recommended the IR physician. Additionally, she was reassured 
about having the procedure by the self-assured nature of the IR physician.  
 Patient A did experience complications after her procedure and was required to 
stay in the hospital for a few days.  However, she indicated she was nonetheless satisfied 
with the information she received during the IC process. She suggested that that if other 
patients did not have the amount of information she did prior to the IC process, they may 
need more information regarding medical terms and how the procedure was done than 
she received during her pre-procedure visit. 
Participant B. Participant B is a 47-year-old man who had a de novo TIPS 
procedure.  He was referred by his liver specialist to the IR physician for a de novo TIPS 
procedure consultation due to the portal hypertension caused by the cirrhosis. 
 Participant B’s experience with the IC process was not as positive as that of 
Participant A.  He is the participant mentioned above who had to wait nearly one and a 
half hours past the scheduled appointment time for the IC visit. This was the first thing 
that he mentioned when asked to describe the IC process, and this delay seemed to set the 
tone for the visit.   
 When asked about his experience with the IC process, Participant B focused many 
of his remarks on the IR physician.  Participant B mentioned that the physician was 
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“honest” and “factual” in his delivery of the information about the TIPS procedure and 
described the risks and benefits and how procedure would be performed. Participant B, 
however, complained that the physician seemed “in a hurry” and drew a diagram by hand 
to show how the stent would travel through the liver, whereas Participant B would have 
expected a more polished visual given the expense of the surgery. He remarked several 
times that he found the physician’s very self-assured demeanor to be off-putting, but 
indicated that the physician’s confidence and experience were reassuring, such that 
Participant B had no fear about having the procedure.  
 Participant B recalled being told the risks and benefits of his procedure. The 
physician told him he was a “great candidate” for the procedure, which would get the 
blood flowing from his liver to his heart. He stated, “He [the physician] told me if I quit 
drinking I may never have to have a liver transplant.” In regards to risks, Participant B 
remarked that the physician told him that “one or two percent of the people in my 
situation die in the first sixty days.” Participant B recalled that he was told about the risks 
of anesthesia, bleeding, and blood clots. Participant B indicated that he decided “right 
then” [during the IC visit] to have the procedure.  
 Participant B revealed that his girlfriend accompanied him to the IC visit and 
asked one or two questions.  The couple was sent home with several pages of information 
about the TIPS procedure. After the IC visit, Participant B’s girlfriend sought additional 
information on the internet, which the couple found to be very consistent with 
information provided to them by the physician. 
 In regards to satisfaction with the IC process, Participant B was generally satisfied 
with the amount of information he was given, but, as stated above, he would have wanted 
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an “extremely well drawn out diagram” and a process that was “more professional.” He 
stressed that although he was not fearful because his risks were low, he surmised other 
people might be “pretty darned worried” and might appreciated the opportunity to speak 
with a patient who had had a de novo TIPS procedure or having a video tape to view at 
home.  
 Participant B’s procedure went well but he listed a series of complaints about his 
post-procedure experiences. He was dissatisfied with the lack of communication with 
waiting family members, delay in being transferred to a room, and a long wait in being 
given something to eat.  Nonetheless when summing up the IC process, he stated, “It 
seemed straightforward to me…  The actual consent form I’m sure was drawn up by 
doctors and lawyers alike.” 
Aim Four: Explore how the IC experiences of patients who underwent a de 
novo TIPS, TACE, or TARE procedure in an IR Department differ according to 
their levels of health literacy 
 The purpose of this exploratory aim was to examine if there were any differences 
in how participants experienced the IC process based on their health literacy level. As 
stated above, the investigator administered the NVS (https://www.pfizer.com/helath/ 
Literacy/public-policy-researchers/nvs-toolkit) assessment for health literacy just prior to 
their interview.  According to the developers of this assessment, a score of 0-1 indicates a 
“high likelihood of limited literacy,” a score of 2-3 indicates “the possibility of limited 
literacy,” and a score of 4-6 indicates “almost always indicates adequate literacy.” None 
of the participants scored in the 0-1 category, 8 participants scored between 2-3, and 6 
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scored between 4-6.  The participants were placed into two groups based on these scores 
(“possibility of limited literacy” and “almost always indicates adequate literacy”).   
Only a few participants in either group made remarks indicating that they had trouble 
understanding information presented to them during the IC process, were given 
information with terms that were too technical or difficult to understand, or had 
misinterpreted information given to them. Moreover, no manifest differences were 
detected between the groups in the number or nature of these remarks. For example, the 
group that scored in the range of “possibility of limited health literacy” was not more 
likely to comment that they struggled to understand information presented to them than 
the group that scored in the range of “almost always indicates adequate literacy.” 
Moreover, as seen in Tables 2-4 (Appendix G), the groups did not differ significantly on 
the number of risks and benefits identified by the participants (Table 5, Table 6), whether 
or not the participants sought information from the internet, whether or not they asked 
questions during the IC process, and whether or not they were satisfied with the IC 
process generally. Overall, therefore, the role of health literacy did not seem to 
discernibly influence the participants’ narratives related to their IC experience.  
Summary of Findings 
 The participants provided adequate information to address each study aim and 
most could clearly recall the IC process. When describing the process, the participants 
focused on their interactions with staff and the IR physician, the feelings that arose 
during the process, the support they received from family and friends who accompanied 
them, and how they made the decision to have the procedure. The main benefits of the 
procedures that the participants recalled being told about during the IC process were the 
 74 
extension of their life expectancy and the freedom from parenthesis. The main risk of the 
procedures that the participants recalled being told about during the IC process was 
bleeding. They were also told there was some risk of death, although some were 
reassured that this risk was small because of their overall health status. Some participants 
were quite frightened about having the procedures, whereas others were confident that it 
would turn out well. All were convinced that their procedure was necessary given their 
health status, and none debated extensively about whether to have the procedures done or 
not. Most of the participants were satisfied with the IC procedure overall, although a few 
would have liked some medical terms being explained and the procedure being 
diagrammed more adequately.  Health literacy did not seem to have a major influence on 
how the participants experienced the IC process.  
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CHAPTER FIVE-DISCUSSION 
The purpose of this study is to examine the IC procedure as it was experienced by 
patients who underwent a de novo TIPS, TACE, or TARE procedure in an IR 
Department.  This chapter will summarize the study findings and discuss several major 
findings as they relate to existing literature on the IC process, outline the study 
limitations, provide suggestions for future research, and discuss clinical implications. 
Summary of Findings 
 The study findings provide a description of how patients undergoing a complex 
IR experienced the IC procedure based on their own words. When asked to describe the 
IC procedure, the participants focused on their interactions with their providers, the 
emotions the participants experienced during the IC visit, the support persons present 
during the visit, and their decision to have the procedure. They recalled being informed 
about how their procedure was to be performed; the care they would need before, during, 
and after the procedure; and some of the benefits and risks to the procedure. Most were 
satisfied with the IC process although a few mentioned some sources of dissatisfaction. 
The health literacy level of the participants did not seem to influence the responses of the 
participants to the IC process. Several of the major findings resonated with the findings 
of prior studies.   
Findings and Prior Literature 
One key finding in the current study was that interactions with the providers 
during the IC visit were important to participants. Unlike the on-going relationships they 
had with their routine health care providers, the IC visit was a brief encounter focused 
specifically on the procedure. While most research focuses on patient-provider 
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relationships in on-going care, a few studies have examined the nature of these 
relationships in single encounters. Keating et al. (2002), for example, examined the 
relationship between trust in physicians and problems experiencing during an office visit 
(e.g., physician not giving patients enough time to explain the reason for their visit, 
physician not providing understandable answers to questions) and found that lower trust 
in the physician was associated with each problem. Several participants in our study 
indicated the IC process was acceptable not because of good rapport with the provider but 
because they had trust in the IR physician due to his renowned expertise, which was often 
more important than his “bedside manner.”  Just as our participants were seemingly 
reassured when told how their procedure would improve their life-threatening symptoms, 
a phenomenological study of patient perceptions of general practice consultations 
(Anden, Andersson, & Rudebeck, 2005) revealed that patients most wanted a cure, 
symptom relief, or an understanding or confirmation of “what they had.”  Therefore, our 
findings and these findings related to one-time consultations suggest that the promise of 
successful outcomes rather than interpersonal considerations may be most important 
during these visits.  
 Other studies have also addressed our finding that even participants who 
recounted similar risks varied in terms of how serious they perceived these risks to be. 
This may have been because some of our participants perceived their risks to be low 
because they were told they were in the top percent of “good candidates” based on their 
overall health status at the time of the procedure. Indeed Zipkin et al. (2014), based on a 
systematic review, concluded that risks should be presented to patients based on their 
individual risk level instead of risks to the population as a whole.  Yet we found some of 
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our participants nonetheless seemed to downplay the risks of the procedure, which was 
similar to a finding in a study by Lloyd (2001). In this study, participants tended to 
underestimate their own risks when compared to others, a phenomenon Lloyd terms 
optimism bias. He argued that risk information given to patients is often not used in 
decision-making regarding treatments and may be less important than how persons 
perceive their own risks or than other factors or concerns. 
Only a few participants in our study were dissatisfied with the amount of 
information they received during the IC process. Prior studies suggest that satisfaction 
with the amount of information received may be due to individual factors. For example, 
Rood et al. (2015) discussed how patients dealing with threatening information use one of 
two coping styles: monitoring (seeking threatening information) and blunting (avoiding 
threatening information).  In a sample of patients with hematological malignancies, the 
authors found these coping styles were related to the need for information, information 
satisfaction, and involvement in treatment decision-making in complex ways. Thus, the 
need for information and satisfaction with information provided is likely based on a 
variety of factors, some of which are unique to the patient. 
A few of our participants did indicate that would have liked better diagrams to 
explain the procedure and the use of simpler terminology. The success of using visual 
materials to explain complex procedures has been discussed in the literature. In a study of 
patients undergoing a TACE and TIPS procedure and a Inferior Vena Cava (IVC) filter 
placement, the researchers developed educational DVDs for patients to view (Koh, 
Degerstedt, Addicott, & Schenning, 2018). The use of the DVDs resulted in better 
understanding of the procedures when compared to verbal explanations alone.  
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Additionally, those participants who viewed the DVDs before speaking with the IR 
physician received lower doses of sedation during their procedure and reported higher 
intraprocedural comfort levels (Koh, Degerstedt, Addicott, & Schenning, 2018).   
While several of our findings resonate with prior literature, the study will make a 
unique contribution as it is one of the only studies that has queried persons about their 
perspectives on the IC process for a complex IR procedure.  This approach revealed some 
nuances to understanding the patient experience that had not been dealt with in-depth in 
prior literature.  For example, while prior literature suggested that “good” patient-
provider communication contributes to satisfaction with the IC process (Agnew & 
Jorgesen, 2012; Daniels & Vogel, 2012; Fisher, Johnstone, & Williamson, 2011), our 
findings suggest that the assuredness of the provider may be more important that a 
supportive communication style. Similarly while prior literature has focused on patient 
satisfaction with the amount and type of information presented about procedure risks, our 
findings suggest that satisfaction with the IC process may be as influenced by extraneous 
factors surrounding the visit such as wait times (Agnew & Jorgensen, 2012; Mayberry & 
Mayberry, 2001; Rahman, Clamp, & Hutchinson, 2011).  Our study is also one of the 
only that addresses in-depth the feelings and emotions patients experience during the IC 
visit and the important role of the support persons who accompany them to this visit. 
Our findings are consistent with some components of the CSM (Leventhal, 
Brissette, & Leventhal, 2003; Leventhal et al., 2014; Leventhal, Phillips, & Burns, 2016). 
For example, several of the domains of illness representation in the model were evident 
in our findings.  In regards to the identity domain, participants perceived signs and 
symptoms of their illness to be life-threatening and life-altering. Because their liver 
 79 
disease was typically advanced, most did not debate about whether or not to have the 
procedure because not having the procedure did not seem like a real option. In regards to 
the timeline domain, while the participants’ diseases were chronic, the need for the 
procedure was acute, and therefore there was a sense of urgency in decision-making. All 
consented to the procedure at the time of the encounter with the IR physician, and none 
took the document home to think about the decision. In regards to the consequence 
domain, some participants believed the procedure would improve their quality of life by 
decreasing or eliminating the need for frequent paracentesis or managing their esophageal 
varices. Other participants believed that the procedure would save or prolong their lives 
or provide a bridge to transplantation. In regards to the domain of control, the participants 
placed their confidence in the skills of IR physician who was a renowned expert on the 
procedures (Leventhal et al., 2014). The feedback loop is thus clearly reflected in the 
study findings; the participants judged a severe threat to their health status and elected to 
have their procedures despite the risks as the benefits of the procedure were essential to 
their survival.  
Limitations 
 
 The targeted sample size for this study was approximately 20 to 30 participants, 
which is typical for QD studies (Kim, Sefcik, & Bradway, 2016). However, the final 
sample size was 14 because recruitment proved particularly challenging. The recruitment 
challenges were primarily related to the serious nature of the illness that was being 
treated by the procedures.  Many potential participants who were contacted stated they 
were too ill to participate, some had been placed into extended care facilities, several had 
died, and a few were incarcerated. However, the data provided by the 14 participants 
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proved to be adequate to address the primary study aims. Although the smaller sample 
provided rich information related to the participants’ experiences with the IC process, a 
larger sample would have captured more variation in descriptions of IC experiences and 
thus more robust findings.  
 The sample also lacked ethnic diversity. Thirteen of the participants were white, 
two had some Native American ancestry, and one was Black/African American. Because 
so few minority persons participated in the study, no claims can be made about how 
ethnicity might have influenced the participants’ experiences of the IC process. 
Participants from racial and/or ethnic minorities, for example, may have different 
perspectives with regard to the quality of their interactions with HCPs or with their 
satisfaction with the IC process. 
 Focusing only on three similar IR procedures also limited claims that can be made 
about the IC process more generally. In particular, the finding that the participants did not 
tend to debate whether or not to have the procedures based on the information given to 
them during the IC process probably reflects the seriousness of their illnesses and that the 
procedures were necessary to extend their lives.  The decision-making process would 
likely be different for elective procedures or for situations in which there were other 
equally promising options for treatment. Moreover, only those persons who agreed to 
have the procedures were included in the sample so it is unclear how the IC process 
differed for those who refused the procedure. Including a variety of types of procedures 
and sampling participants who engaged in the IC process but declined a procedure would 
have likely provided a broader view of the IC process and possibly yielded different 
findings with regards to the study aims.   
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 Although enrollment was open at three hospital sites, all subjects were recruited 
from one hospital, which is well-known for performing TIPS, TARE, and TACE 
procedures. Additionally, only one IR physician performed all of the procedures for the 
participants. This provider is nationally recognized in the performance of the all three 
procedures and performs the majority of them at this hospital. The IC process may have 
varied for persons who had the procedures done at different sites by a different IR 
physician.  However, while the participant responses to the IC process might be specific 
to the physician’s stature and personal style of interaction, or to IC procedures that are 
standard at the site, the findings nonetheless suggest important factors that matter to 
persons undergoing procedures needed to extend their lives.  
 The measurement of health literacy using the NVS (Pfizer, n.d.) also posed a 
limitation. Researchers agree that no single tool can adequately assess the subjective and 
objective aspects of health literacy (Altin, Finke, Kautz-Freimuth, & Stock, 2014).  In 
particular, the NVS (Pfizer, n.d.) has been critiqued because the scoring categories (i.e., 
high likelihood of limited literacy, likelihood of limited literacy, likelihood of adequate 
literacy) lack precision, and calls have been made for additional studies on the reliability 
and validity of the tool (Pfizer, n.d.) (Mancusco, 2009). Therefore, the health literacy 
scores obtained from the NVS (Pfizer, n.d.) for our participants may not have been 
adequate to uncover the influence of health literacy on the experience of providing IC.  
Suggestions for Future Research 
 
 To further research in the IC process experience, researchers should recruit 
participants from a variety of sites. Studies conducted at tertiary medical centers that 
regularly perform TIPS, TARE, and TACE procedures with diverse racial and ethnic 
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populations could provide robust participant narratives from varying cultural viewpoints.  
Moreover, researchers may wish to compare the narratives of participants who have 
undergone a medically necessary procedure to those participants who have had truly 
elective procedures such as cosmetic surgeries. Additional insight could be gained if 
participants perceived an actual choice between one treatment or another for their 
condition, such as having the option of taking a medication in lieu of having a surgical 
procedure. 
 Recruiting subjects who have interacted with a variety IR physicians at a variety 
of different sites would help determine what findings are provider- or site-specific. 
Differences in how healthcare delivery systems conduct IC processes likely contribute to 
the patient experiences in either negative or positive ways.  
 While our findings provide a description of how persons experience the IC 
process, what information they remember being told about their procedures, and their 
general satisfaction, we recognize that agreement to undergo a procedure that involves 
considerable risk is not a point-in-time event but rather a dynamic process of engagement 
that is influenced by a host of contextual factors. Future researchers should explore how 
persons decide to have healthcare procedures by conducting longitudinal studies that can 
contextualize consent as one aspect of patient engagement that evolves over time and that 
is influenced by a number of factors. Such factors might include input from their primary 
care or specialty providers, personal factors such beliefs and attitudes about their illness, 
influence of support persons, and the changing nature of their illness.  
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Clinical and Practical Applications 
 
  Nurses and HCPs may use the results of this study to better understand the 
patient experience during the IC process and to consider best practices related to IC. For 
example, while a positive “bedside manner” is always a best practice, patients might be 
as interested in provider comportment that suggests self-assurance and self-confidence. 
They may feel that provider confidence outweighs interpersonal warmth in one-time IC 
encounters as they are most concerned about having their fears and concerns about the 
procedure alleviated.  The IC process thus might include information about the provider’s 
expertise and success rates.  
 Our findings indicate that patients might benefit from being told of their personal 
risk due to their current health status rather than being merely informed of what risks are 
associated with the procedure more generally. Moreover, a few participants mentioned 
that some information presented to them included jargon that was hard to understand, 
which reinforces that providers should present information in straightforward terms and 
confirm that patients understand the information and interpret it in a way that is accurate. 
Some participants requested providers use supplement verbal information with visual 
materials such as pictures and/or models when describing procedures that are complex in 
nature. Providers may consider developing DVDs or other technology-enhanced 
programs to describe complex radiological procedures such as those that were the focus 
of this study.  
 Because our findings revealed that the participants experienced a variety of 
emotions during the IC process, providers should include time to allow patients to 
express their feelings and discuss any concerns about the procedure they may have. 
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Providers may need to encourage patients to talk about their feelings and concerns as 
patients may consider the IC visit only a time for them to prepare for the procedure.  
 Providers should also consider involving the support persons who accompany the 
patient to the IC visit in discussions. Some of the support persons who accompanied our 
participants asked questions, but many remained quiet.  Support persons who are actively 
engaged in the process could clarify information provided to the patients, ensure that the 
patients understand the information being presented to them, and express the support 
persons’ own concerns and worries.  
 Some of our participants had decided to have their procedures before the IC 
process and before they formally learned about the benefits and risks.  Providers should 
ask patients about their decision-making process and query about what information was 
instrumental in their decisions.  This would help ascertain what factors influenced 
patient’s decisions to have the procedure and provide an opportunity to clear up any 
misinformation.  
Our findings suggest that while it is important for providers to inform their 
patients about the procedure itself, it is also important to address pragmatic issues such as 
how long they are slated to stay in the hospital, when they may return to work, what will 
be required for follow-up care, and what changes they might expect to their quality of 
life. To be fully informed about a procedure, patients need to know how they will be 
cared for before, during and after the procedure, especially if they have had few 
procedures or surgeries in the past.  
 While participants’ satisfaction with the IC process was closely tied to the amount 
and quality of information given them, providers should consider that satisfaction with 
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the IC process is also influenced by circumstances surrounding the visit, such as wait 
times and interactions with support staff that occur before the IC encounter begins.  For 
example, if persons are kept waiting for the appointment in which they consent to the 
procedure, their irritation could affect how they hear and process information about the 
procedure they will undergo. Providers should thus take care to start IC appointments on 
time and afford patients and their support persons ample time to absorb, process, and ask 
questions about information they receive.  
Summary 
 This study demonstrates that persons’ experiences during the IC process are 
multi-faceted and complex.  Many aspects of the IC visit were important to the 
participants including their interactions with providers, especially the IR physician. Most 
recalled being told about similar risks to the procedures during the visit, but interpreted 
their own risk in a variety of ways. The majority were satisfied with the IC process, 
although a few wished to have the information explained in a simpler or more visual way. 
Our findings related to our exploratory aim did not suggest the health literacy influenced 
the participants’ experiences of IC in any obvious ways.  The findings should be 
considered in light of the study limitations including a small, homogeneous sample of 
patients who all had their procedures performed at one site by one IR physician. Future 
studies on this phenomenon should examine the IC process for a variety types of 
procedures, at several sites, and with a more diverse population.  Providers engaged in 
the IC process should remember that while the IC process is an exchange of information, 
it is also an interaction affected by emotions and concerns that should be addressed at the 
encounter. 
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APPENDIX A 
STUDY INTRODUCTION LETTER TO POTENTIAL PARTICIPANTS 
This IRB approved form letter was sent to potential study participants on IU 
Health Radiology Department letterhead.  
 Dear ___________________: 
 
You recently underwent a procedure at (Eskenazi, IU Methodist, or IU University) 
hospital in the Interventional Radiology Department.  I am writing to let you know that a 
research study is being conducted that may be of interest to you.  It is possible that you 
may be eligible to participate in this study; however, only the investigators of the study 
can determine if you meet the requirements to participate. 
 
The study is being conducted by an Indiana University School of Nursing (IUSON) 
faculty member, Dr. Claire Draucker, and Marsha Hughes-Gay, RN, an IUSON doctoral 
student.  The study is examining the experience of patients who participated in an 
informed consent discussion.  If you meet the criteria for participation, you will provide 
some basic medical information, complete an interview, and complete a six question 
health literacy form. 
 
Ms. Marsha Hughes-Gay will contact you by phone to see if you are interested in 
participating.  Please be aware that your participation is voluntary and there are no 
consequences to you if you choose not to participate.   
 
Thank you for your consideration of this study. 
 
Sincerely, 
 
 
Matthew S Johnson, MD FSIR 
Professor of Radiology and Surgery 
Director, Interventional Oncology 
Director, Clinical Research, Department of Radiology 
Indiana University School of Medicine 
Indiana University Health University Hospital  
550 North University Boulevard 
Indianapolis, Indiana 46202-5253 
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APPENDIX B 
INFORMED CONSENT FOR STUDY 
INDIANA UNIVERSITY INFORMED CONSENT    STATEMENT 
FORM 
 
Examination of the Informed Consent Process as Experienced by 
Patients Who Have Undergone a Chemoembolization, Radioembolization or 
Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedure 
  
You are invited to participate in a research study of the experiences of patients who have 
participated in an nformed consent (IC) process for a chemoembolization, radioembolization or 
transjugular intrahepatic portosystemic shunt (TIPS) procedure.  Chemoembolization and 
radioembolization are used to treat cancerous tumors.  A TIPS procedure reduces the pressure of 
blood flowing through the liver.  You were selected as a possible subject because you provided 
IC for one of these procedures in the past three months in the Interventional Radiology 
Department at Indiana University Health University Hospital, Indiana University Health  
Methodist Hospital, or Eskenazi Health. Please read this form and ask any questions you may 
have before agreeing to be in the study.   
  
STUDY PURPOSE  
The purpose of this study is to describe the experiences of patients providing informed consent to 
undergo a chemoembolization, radioembolization or de novo TIPS procedure.  Additionally, the 
study will examine differences of the patient experience based on varying degrees of health 
literacy. 
  
The study is being conducted by Marsha Hughes-Gay, RN, a doctoral candidate from Indiana 
University School of Nursing, under the supervision of her advisor, Claire Burke Draucker, PhD, 
RN, FAAN, of the Indiana University School of Nursing.  
  
NUMBER OF PEOPLE TAKING PART IN THE STUDY  
 If you agree to participate, you will be one of 21 subjects who will be participating in this 
research.  
  
 PROCEDURES FOR THE STUDY  
 If you agree to be in the study, you will do the following things:  
  
1) Complete a demographic document collecting basic information about you including your (a) 
name, (b) date of birth, (c) race/ethnic group, and (d) highest level of education.  
  
2) Complete an assessment of your health literacy levels using the Newest Vital Sign tool.  This 
tool provides a nutritional label and asks between four and six questions about the label.  This 
assessment takes approximately six minutes to complete.  
  
3) Provide information about your health history and medical conditions.  
  
4) Participate in an interview consisting of questions pertaining to your experience during the IC 
process for  
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your procedure.  This interview will last approximately one hour.  The interview may be face-to-   
face, by telephone, or by electronic methods such as FaceTime®, Skype®, or other video chat 
capabilities.  Face to-face interviews may be conducted in your home or other mutually agreed 
area that would allow for privacy (e.g. library study room, community center meeting room).  
  
5) Have your interview audio recorded.  
  
RISKS OF TAKING PART IN THE STUDY  
 While on the study, the risks are:  
• You may experience frustration while completing the health literacy assessment using the 
Newest Vital Sign tool.  
• You may experience feelings of anger or embarrassment when recalling the events of the IC 
process.  
• You may worry about repercussions by healthcare providers in the Interventional Radiology 
Department.  
• The potential loss of confidentiality.  
• There may be risks we do not know about.  
  
Efforts will be made to minimize these potential risks.  The investigator will assist you with the 
Newest Vital Signs tool and you are allowed to take as much time as you need to answer the 
questions.  The purpose of this research is to better understand your experience during the IC 
process so there are no wrong or right answers during the interview portion of the study.  
Participation in this study will not affect your care. Your individual identity will not be disclosed 
to the staff in the Interventional Radiology Department. No identifiable information about your 
interview or survey responses will be shared with care providers.  All study documents are kept 
on a secured server and paper forms are kept in locked cabinets in locked offices in an office area 
that has limited access.  
  
BENEFITS OF TAKING PART IN THE STUDY  
 There is no direct benefit to participating in this study.    
  
ALTERNATIVES TO TAKING PART IN THE STUDY  
 Instead of being in the study, you may choose to not participate  
  
CONFIDENTIALITY  
 Efforts will be made to keep your personal information confidential.  We cannot guarantee 
absolute confidentiality.  Your personal information may be disclosed if required by law.  Your 
identity will be held in confidence in reports in which the study may be published and databases 
in which results may be stored.  The audio recordings and the transcript of the recording will be 
stored on a secure server that requires a password. These will be stored for a period of seven 
years as required by Indiana State law  
  
Organizations that may inspect and/or copy your research records for quality assurance and data 
analysis include groups such as the study investigator and his/her research associates, a 
transcription service, the Indiana University Institutional Review Board or its designees, the 
Indiana University School of Nursing, and (as allowed by law) state or federal agencies, 
specifically the Office for Human Research Protections (OHRP) who may need  
to access your research records.  
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COSTS  
Taking part in this study may lead to added costs to you in the form of transportation to the 
interview site if not conducted in your home.  If the interview is conducted by telephone or other 
electronic means (such as Skype® or Facetime®) your phone and data plan may charge you for 
additional minutes or data usage.   
  
PAYMENT  
You will receive payment for taking part in this study.  The payment is a twenty-dollar ($20) 
Wal-Mart gift card.   
Payments is made when the demographic form, health history summary, assessment of health 
literacy using the  
Newest Vital Sign, and interview is completed.  There is no gift card payment for partial 
completion of the study  
  
 FINANCIAL INTEREST DISCLOSURE  
 The costs associated with this study may be partially or fully paid for by a grant provided to 
Marsha Hughes-Gay, MSN, MPH, RN as part of a dissertation program.    
  
CONTACTS FOR QUESTIONS OR PROBLEMS  
 For questions about the study contact the researcher, Marsha Hughes-Gay, RN at (office number/ 
mobile number) or Dr. Claire Draucker, RN, at (office number).  If you cannot reach the 
researcher during regular business hours (i.e., 8 a.m. to 5 p.m.), please call the IU Human 
Subjects Office at 317-278-3458.  After business hours, please call Marsha Hughes-Gay at 
(mobile number) 
  
In the event of an emergency, you may contact Marsha Hughes-Gay, RN at (mobile number).  
  
For questions about your rights as a research participant, to discuss problems, complaints, or 
concerns about a research study, or to obtain information or offer input, contact the IU Human 
Subjects Office at 317-278-3458 or 800-696-2949.  
  
VOLUNTARY NATURE OF THIS STUDY  
 Taking part in this study is voluntary.  You may choose not to take part or may leave the study at 
any time.  Leaving the study will not result in any penalty or loss of benefits to which you are 
entitled.  Your decision whether or not to participate in this study will not affect your current or 
future relations with Indiana University Health, Eskenazi Health, or the Indiana University 
School of Nursing.   
  
Your participation may be terminated by the investigator without regard to your consent in the 
following circumstances: If you cannot complete the Newest Vital Sign assessment or participate 
in the interview independently  
  
SUBJECT’S CONSENT  
 In consideration of all of the above, I give my consent to participate in this research study.    
 I will be given a copy of this informed consent document to keep for my records.  I agree to take 
part in this study.  
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Subject’s Printed Name:  ___________________________________________ 
  
Subject’s Signature_________________________________: Date:  ____________ 
                                                                                                (must be dated by the subject)  
  
Printed Name of Person Obtaining Consent:  _________________________________ 
  
Signature of Person Obtaining Consent: ____________________Date:  __________________ 
  
  
  
  
 
 
 
  
May 2, 2017 v07/2015 3   
 
                    Protocol 1605909865 IRB Approve 
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APPENDIX C 
HEALTH SUMMARY FORM 
 
Patient Name: __________________________________  MRN ______________ 
Patient’s insurance coverage (circle one):  Private    Medicaid   Medicare   None/self-pay 
        Other: ___________________________ 
 
Medical reason for the IR procedure:  _________________________________________ 
Date of : Pre-Procedure IR clinic visit: __________________________ 
Did the potential subject sign the Procedure consent?    Yes    No-signed by 
someone else (Stop) 
IF THE POTENTIAL SUBJECT DID NOT SIGN THE CONSENT 
FOR THE PROCEDURE—DO NOT PROCEED—SCREEN FAIL 
 
Date Informed Consent signed: ____________________ 
 
Informed consent process by:  _________________________MD   PA  RN-NP 
 
Date of IR procedure:  ___________________________________ 
 
Facility:  University Hospital Methodist Hospital Eskenazi Hospital 
 
IR procedure performed by: _________________________________________________ 
 
Date of 1 month IR follow up (if appl): ________________________________ 
  
If a TIPS procedure (pre procedure if calculated)  (if calculated) MELD score:  ________ 
                                    Child-Pugh score: ______ 
 
A review of the medical hx at the time of pre-procedure appointment, the patient had/has 
the following conditions: 
  Anemia    Angina / chest pain   CAD    CHF 
  COPD    CVA                Diabetes      Cirrhosis 
  Hepatitis B   Hepatitis C    Hypertension  
  Cancer, type _______________________________________ 
   
  Neurological disorder:   Alzheimer’s      Parkinson’s       Huntington’s  
Other _________________ 
Other hx: _____________________________________________________________ 
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Has the patient had the following in the last 2 months: 
   Chemotherapy 
   Dialysis—type_______________ 
   Radiation treatment 
 
Is the patient on the liver transplant list at the time of the Pre-procedure clinic visit?  
   Yes       No  
  
At the time of IR procedure was the patient on oxygen therapy?     Yes       No 
 
In the 48 hours post procedure procedure, did the patient experience any adverse events 
or complications? 
If so, list (include tx’s provided): 
_______________________________________________________________________ 
 
________________________________________________________________________ 
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APPENDIX D 
 
DEMOGRAPHIC FORM 
Subject Demographic Form 
Name: _____________________________________________________ 
Date of Birth: __________________________   Gender:    Male       Female 
Race/Ethnic Group:     
  Asian  
  Caucasian / White 
  Black / African American 
  Hawaiian / Other Pacific Islander 
  Native American / Alaska Native / First Nation 
  Other, please describe: __________________________ 
 
Are you: 
   Hispanic or Latino 
   Not Hispanic or Latino 
 
What is your highest level of education? 
  Less than high school (K-8th grade)     Master’s Degree 
  High school, did not graduate      Doctoral degree  
  High school diploma / GED 
  Some College—did not graduate 
  Bachelor’s degree 
 
 
 
 
 
 
 
 
 
 
 94 
 
APPENDIX E 
 
NEWEST VITAL SIGN ASSESSMENT TOOL 
 
 
 
 
 
 
 
This label is provided to the participant.  The scoring sheet is completed by the person 
administering the assessment (next page).   Interpretation is provided below the scoring 
sheet 
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APPENDIX F 
STUDY PARTICIPANT DEMOGRAPHICS 
Total Participants N=14 
 Number of Participants Percentage of Participants 
Gender 
   Male 
   Female 
 
8 
6 
 
57.1 
42.8 
Race-(self identified) 
  White/Caucasian 
  Black/African American 
  White/Caucasian &  
  Native American 
 
11 
1 
2  
 
78.5  
7.1 
14.3 
Ethnicity 
  Hispanic 
   Non-Hispanic 
 
1 
13 
 
7 
92.8 
Age in years 
  ≤ 50  
  ≥ 50 
 
3 
11 
 
21.4 
78.5 
Highest level of 
education 
   < High School Diploma 
   High School Diploma 
   Some college/vocational 
   Bachelor’s Degree 
   Not disclosed 
 
 
2 
7 
3 
1 
1 
 
 
14 
50 
21.4 
7 
7 
NVS Health Literacy 
Score 
  0-1 
  2-3 
  4-6 
  
 
0 (zero) 
8 
6 
 
 
0 (zero) 
57.1 
42.8 
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APPENDIX G 
 
COMPARISON OF POSSIBLY LIMITED LITERACY AND ALMOST ALWAYS 
ADEQUATE LITERACY GROUPS 
 
Table G-1 Participant use of the internet to find information on procedures 
Group Sought information on 
internet 
Did not seek 
information from 
internet 
Possibly limited literacy 3 5 
Almost always adequate 
literacy 
4 2 
Fisher’s Test p-value 0.5921  not significant 
 
  
 
*one subject did not specify satisfaction. 
Table G-4 Participant recall of risks discussed during IC process 
Group Total Number of recalled 
risks 
Test of proportion = 
0.50 p-value 
Possibly limited literacy 10 (41.67%) 0.4142 
Almost always adequate 
literacy 
14 (58.33%) 
 
 
 
 
 
Table G-2 Participants use of questions during IC process 
Group Asked questions during 
IC process 
Did not ask questions 
during IC process 
Possibly limited literacy 4 4 
Almost always adequate 
literacy 
4 2 
Fisher’s Test p-value 0.6270 not significant 
Table G-3 Participant satisfaction with IC process 
Group Satisfied with IC process Not satisfied with IC 
process 
Possibly limited literacy 7 1 
Almost always adequate 
literacy 
4 1 
Fisher’s Test p-value 0.9999 not significant 
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Table G-5 Participant recall of benefits discussed during IC process 
Group Total Number of 
recalled benefits 
Test of proportion = 
0.50 p-value 
Possibly limited literacy 9 (64.29%) 0.2850 
Almost always adequate 
literacy 
5 (35.71%) 
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